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A chemical-genetic study of EphB receptor tyrosine kinase signaling in 
the developing nervous system 
 
Abstract 
 
EphB receptor tyrosine kinases regulate cell-cell contacts throughout nervous 
system development, mediating processes as diverse as axon guidance, topographic 
mapping, neuronal migration and synapse formation. EphBs bind to a group of ligands, 
ephrin-Bs, which span the plasma membrane, thus allowing for bidirectional signaling 
between cells. Since EphBs are capable of multiple modes of signaling, and since they 
regulate numerous interdependent stages of development, it has been challenging to 
define which signaling functions of EphBs mediate particular developmental events. 
To overcome this hurdle, we developed an approach combining chemical biology 
with genetic engineering to reversibly inhibit EphB receptors in vivo. By mutating a 
residue in the receptor’s ATP-binding pocket, we rendered its kinase activity sensitive to 
reversible inhibition by PP1 analogs that do not inhibit wild type receptors. We 
engineered triple knockin mice bearing this mutation in which the kinase activity of 
EphB1, EphB2, and EphB3 can be rapidly, reversibly, and specifically blocked. Since we 
are able to block the kinase activity of EphBs while leaving their scaffolding and reverse 
signaling capabilities intact, we can precisely isolate the role of the kinase domain. In 
addition, acute inhibition can circumvent the developmental compensation that may   iv
occur after genetic mutations and can even allow the controlled study of EphBs in the 
mature brain and in disease models. 
Using these mice, termed analog-sensitive EphB triple knockin (AS-EphB TKI) 
mice, we demonstrate a requirement for the kinase-dependent signaling of EphBs in the 
collapse of retinal ganglion cell growth cones in vitro and the guidance of retinal axons at 
the optic chiasm in vivo. In addition, we show that the formation of several cortical axon 
tracts, including the corpus callosum, requires EphB tyrosine kinase signaling. In contrast, 
we find that steps in synapse development that are thought to be EphB-dependent occur 
normally when the kinase activity of EphBs is inhibited. We conclude that a cardinal in 
vivo function of EphB signaling, the ability to mediate axon guidance via growth cone 
repulsion, requires the tyrosine kinase activity of EphBs, while the development of 
functional excitatory synapses is independent of EphB tyrosine kinase activity. 
   v
Table of Contents 
 
 
Abstract..............................................................................................................................iii 
List of Figures...................................................................................................................vii 
List of Tables...................................................................................................................viii 
Acknowledgments.............................................................................................................. xi 
Attributions..........................................................................................................................x 
 
1    Introduction                            1 
1.1  Receptor tyrosine kinases in nervous system development..........................................2 
1.2  The Eph family of receptors  ........................................................................................6 
1.3  EphB receptor function in the developing nervous system  .......................................13 
1.4  EphB receptor signaling .............................................................................................21 
1.5  Previous approaches to studying EphB signaling.......................................................24 
1.6  Summary of dissertation.............................................................................................31 
 
2    A chemical-genetic approach to studying EphB signaling               33 
2.1  Background ................................................................................................................34 
2.2  EphB analog-sensitive kinases ...................................................................................37 
2.3  Generation of AS-EphB TKI mice  ............................................................................43 
2.4  Discussion ..................................................................................................................55 
2.5  Materials and methods................................................................................................57 
 
3   EphB receptor tyrosine kinase signaling in axon guidance                         66 
3.1  Background ................................................................................................................67 
3.2  EphB tyrosine kinase activity in growth cone collapse .............................................71 
3.3  The kinase activity of EphBs is required for axon guidance at the optic chiasm.......76 
3.4  EphB tyrosine kinase signaling regulates the formation of cortical tracts..................80 
3.5  Discussion...................................................................................................................85 
3.6  Materials and methods................................................................................................88   vi
 
4  EphB receptor tyrosine kinase signaling in synapse development                 92 
4.1  Background ................................................................................................................93 
4.2  EphB tyrosine kinase signaling is dispensable for synapse and spine formation ......97 
4.3  Discussion.................................................................................................................108 
4.3  Materials and methods..............................................................................................110 
 
5  Conclusion                                                        114 
 
Bibliography                                                                                                          120 
   vii
List of Figures 
 
 
1.1  Structure of EphBs and their ligands ephrin-Bs ...........................................................9 
1.2  Expression of EphBs and ephrin-Bs in cortical neurons  ...........................................12 
2.1  Analog-sensitive kinase alleles (ASKA)  ...................................................................36 
2.2  Sequence alignment of EphB kinase domains ...........................................................38 
2.3  Rapid, reversible, and selective inhibition of AS EphBs............................................39 
2.4  Dose-response curves of EphB inhibition after treatment with PP1 derivatives........41 
2.5  AS-EphB KI mouse targeting strategy  ......................................................................44 
2.6  Validation of the AS mutation in AS-EphB TKI mice ..............................................47 
2.7  Normal EphB expression and surface localization in AS-EphB TKI mice................49 
2.8  EphB clustering persists in the absence of EphB tyrosine kinase activity .................50 
2.9  Selective inhibition of EphBs, but not EphAs, in AS-EphB TKI neurons ................52 
2.10  PP1 derivatives block the phosphorylation of EphB substrates in AS-EphB TKI 
neurons ..............................................................................................................................54 
3.1  EphB-dependent growth cone collapse in retinal explants.........................................72 
3.2  Reversible  blockade of growth cone collapse in AS-EphB TKI explants.................75 
3.3  The formation of the ipsilateral retinal projection requires EphB tyrosine kinase 
signaling.............................................................................................................................78 
3.4  EphB tyrosine kinase activity is required for the formation of the corpus callosum..82 
3.5  The proper formation of the anterior commissure requires EphB tyrosine kinase 
function..............................................................................................................................84 
4.1  EphB tyrosine kinase activity is dispensable for the formation of functional 
excitatory synapses in vitro................................................................................................98 
4.2  The assembly of synapses does not require EphB tyrosine kinase activity .............100 
4.3  EphB tyrosine kinase activity is not required for dendritic spine development in 
culture ..............................................................................................................................102 
4.4  EphB tyrosine kinase signaling is not required for dendritic spine development in 
hippocampal slices...........................................................................................................104 
4.5  Analysis of dendritic spines in EphB2 shRNA-transfected neurons........................107   viii
List of Tables 
 
 
2.1  Primers used in the generation of AS-EphB TKI mice...............................................59 
3.1  Summary of cortical phenotypes in AS-EphB TKI and WT mice  ............................81   ix
Acknowledgments 
 
 
I would like to thank my advisor Michael Greenberg for his unwavering support 
throughout my PhD. He has provided an outstanding example of how to stay grounded 
and treat people with true respect which I can only hope to emulate. Mike fills his lab to 
the brim with intelligent and kind scientists. In particular Bulent Ataman, Alex Rubin, 
and Athar Malik have all contributed at times to my work. Shannon Robichaud and 
Janine Zieg have kept the lab running. Linda Hu has generated essential antibodies and 
Ping-Ping Zhang has helped enormously with mice. Most importantly, my collaborator 
Henry Ho has been the perfect mix of good nature and comic relief. 
The members of my dissertation advisory committee have provided helpful advice 
for which I am grateful. Thanks to Josh Kaplan, Chinfei Chen, Lew Cantley, and Jeff 
Lichtman. In addition, PiN program chair Rick Born along with administrators Gina 
Conquest and Karen Harmin have all worked hard to keep me on track. 
My thesis work was made possible by several excellent collaborators. Chao 
Zhang and Michael Lopez in the laboratory of Kevan Shokat gave support and guidance 
with chemical-genetics and provided crucial reagents. Michael Robichaux in the 
laboratory of Chris Cowan was invaluable in studying cortical tracts, and Carol Mason 
and her lab members provided assistance for work in the visual system. 
I have been fortunate to learn from many scientific friends along the way 
including Mark Philips, Ian Ahearn, Trever Bivona, Hillel Adesnik, and Gregorio Valdez. 
Finally, I would like to thank my parents, David and Carole Soskis, for their 
support, solid values, and crucial role in the development of my own nervous system.  x
Attributions 
The EphB-AS TKI mice were originally generated by Henry Ho. Chao Zhang and Kevan 
Shokat provided the intellectual foundation for the analog-sensitive kinase allele strategy. 
All further characterization and experimentation was performed by Michael Soskis under 
the guidance of Michael Greenberg with the following exceptions: 
 
Figure 1.2 uses publicly available data generated by the Greenberg lab. 
Figures 2.2 and 2.5 were generated by Henry Ho. 
Figure 2.6 is based on data from Henry Ho, who also generated panels A and B. 
Figure 2.7B is based on data collected by Bulent Ataman. 
Figures 3.4 and 3.5 are based on data from a collaboration between the laboratories of 
Michael Greenberg and Chris Cowan at the University of Texas Southwestern. 
Experiments were performed by Michael Soskis, Henry Ho, and Michael Robichaux. Chapter 1 
Introduction   2
The human brain may well be the most complex structure in the known universe. 
For it to spring forth fully formed would be incredible; but to self-assemble in the womb 
as it does millions of times a year is even more astounding. 
The question of how the nervous system arises out of a set of genetic instructions 
underlies the major pursuits of developmental neurobiology. Piecing together these 
processes can have profound implications for understanding how the brain works, how 
humans evolved, how diseases lead to nervous system dysfunction, and how these 
disorders can be treated. 
Unfortunately, “if the human brain were so simple that we could understand it, we 
would be so simple that we couldn't (Pugh, 1977).” It is for this reason, in addition to 
practical and ethical considerations, that we study model organisms such as the worm, fly, 
zebrafish, chicken, and mouse. Decades of work in embryology and developmental 
biology have elucidated the intricate processes that lead from a fertilized egg to an adult 
organism and how the nervous system takes shape. Since the molecular revolution, core 
pathways have been identified underlying these processes. The bottom of the well has not 
yet been reached, as new layers of complexity continue to emerge. 
  Much of development hinges on the precise communication between cells. 
Receptor tyrosine kinases (RTKs) have proven vital to this process in a variety of 
contexts. Understanding how they function in the development of the nervous system and 
how their dysregulation causes disease has been an area of active research, with a Nobel 
prize already awarded and new directions of promising research on the horizon. 
 
   3
1.1 Receptor tyrosine kinases in nervous system development 
The History of RTKs 
Growth factors orchestrate many of the central processes in development. In classic 
experiments conducted by Rita Levi-Montalcini and Stanley Cohen, nerve growth factor 
(NGF), the first growth factor to be isolated, was shown to dramatically affect the 
survival, differentiation, and morphology of cells (Levi-Montalcini, 1987). However, 
despite the importance of growth factors, several decades elapsed until the first relevant 
receptor was identified. This receptor for epidermal growth factor, termed EGFR, 
launched decades of study into how receptors mediate growth factor signals (Carpenter et 
al., 1978). The discovery soon after that EGFR could catalyze the transfer of phosphate 
onto tyrosine residues in proteins made it the prototypical receptor tyrosine kinase, or 
RTK (Ushiro and Cohen, 1980). 
Since the initial characterization of RTKs, 20 subfamilies have been identified in 
humans, with most having known ligands (Lemmon and Schlessinger, 2010). The study 
of RTKs has progressed enormously over the last three decades and at all times been 
closely linked to both normal development and cancerous growth. Many of the early 
RTKs were implicated in tumors, such as the EGFR gene her2 in breast cancer. A great 
deal of work is currently focused on understanding how to develop therapeutics that 
target RTKs as potential cancer therapies (Sawyers, 2002). 
In the nervous system, RTKs have proven to play a key role in many stages of 
development. The ErbB receptors and their ligands, the neuregulins, are particularly 
important for glial development (Mei and Xiong, 2008). Musk and its ligand agrin 
coordinate the assembly of the neuromuscular junction (Sanes and Lichtman, 2001). The   4
neurotrophin receptor family controls a number of processes including the survival and 
determination of electrophysiological properties in neurons (Lu et al., 2005; Luther and 
Birren, 2009). Finally, the Eph receptors and their ligands, the ephrins, control numerous 
cell-cell interactions, including those required for retinotopic mapping (Kullander and 
Klein, 2002). 
 
Signaling by RTKs 
The basic structure of an RTK consists of an extracellular region containing a ligand 
binding motif and an intracellular region containing a catalytic kinase domain, in addition 
to various regulatory regions (Lemmon and Schlessinger, 2010). The fundamental 
principles of RTK signaling were worked out in classic experiments from the 1980s. 
Ligand binding leads to dimerization of the receptor, either as heterodimers or 
homodimers (Schlessinger, 1988). This dimerization occurs through several different 
mechanisms depending on the particular subclass of RTK (Bennasroune et al., 2004). 
Once the dimerized receptors are brought into close proximity, autophosphorylation of 
the receptor greatly enhances its catalytic kinase function (Hubbard and Till, 2000). 
RTK autophosphorylation has two major effects on signaling. First, once the kinase 
domain of the receptor has been activated, it can catalyze the phosphorylation of cellular 
substrates. Second, autophosphorylated residues on the RTK can serve as docking sites 
for adaptor proteins within the cell containing specialized domains, such as the Src 
homology 2 (SH2) domain (Sadowski et al., 1986) or the phosphotyrosine binding (PTB) 
domain (Kavanaugh et al., 1995). In the EGF pathway, receptor activation leads to 
Grb2/Sos binding to phosphotyrosines on EGFR and the activation of Sos, which then   5
activates Ras family small-GTPases that modulate MAPK transcriptional signaling 
(Lowenstein et al., 1992; Rozakis-Adcock et al., 1993). 
 
Atypical RTK signaling 
After the initial characterization of receptor tyrosine kinases, it became apparent 
that other modes of signaling apart from tyrosine kinase activity and SH2-binding domain 
interactions were possible. This was supported by the following lines of evidence: 
First, a surprising finding in kinase research has been the identification of proteins 
in the kinase family that lack catalytic kinase activity. Ten percent of putative kinases 
lack a conserved amino acid in their kinase domain and are therefore thought to be 
pseudokinases (Boudeau et al., 2006). These pseudokinases signal completely 
independently of their deficient kinase domains. Among RTKs, ErbB3 and PTK7, both 
pseudokinases, have been implicated in tumor cell proliferation and cell polarity, 
respectively, despite their inability to phosphorylate protein targets (Holbro et al., 2003; 
Lu et al., 2004). In the nervous system, the catalytically-inactive RTK RYK has been 
shown to mediate WNT signaling in a kinase-independent manner (Bovolenta et al., 
2006). 
Second, several RTKs contain additional signaling domains such as the Src 
Homology 3 (SH3), PSD-95, Dlg, Zo-1 (PDZ), and WW domains. Each of these domains 
regulates protein-protein interactions, suggesting a possible scaffolding role for some 
RTKs that may be independent of their tyrosine kinase activity (Reimand et al., 2012). 
Alternatively, these domains could function in the regulation of receptor kinase activity.   6
Third, several RTKs have been shown to signal through their ligands in a form of 
reciprocal signaling termed reverse signaling. For example, binding of the erbB receptor 
to its ligand, neuregulin-1, can cause proteolytic cleavage of the intracellular region of 
neuregulin, which may then translocate to the nucleus to engage a transcriptional 
pathway (Bao et al., 2003). Thus, erbB, and possibly other RTKs, can function as a 
ligand independent of its kinase activity. 
These pieces of evidence support a role for atypical modes of RTK signaling. Of 
all the subfamilies of RTKs, none has the complexity and sheer signaling potential of the 
Eph receptors, to which all three of the arguments above can apply. 
 
1.2 The Eph family of receptors 
The Eph subclass of RTKs 
The Eph receptors constitute the largest subclass of RTKs. Eph receptors were 
initially isolated from an Erythropoietin-producing human hepatocellular carcinoma cell 
line (Hirai et al., 1987). During normal development, Ephs regulate diverse processes 
including the formation of the nervous, skeletal, and circulatory systems (Pasquale, 2008). 
However, their misexpression and altered signaling can lead to pathologies and have been 
linked to several tumors including breast and colon cancers (Genander and Frisen, 2010). 
The identification of the Eph receptor ligands, the ephrins, required seven more 
years and was reported independently by several researchers: Bartley et al. screened 
Chinese hamster ovary (CHO) cell supernatants for binding to immobilized Eph receptors 
using surface plasmon resonance to identify a protein which they were able to sequence 
(Bartley et al., 1994). Flanagan and colleagues used soluble alkaline phosphatase receptor   7
fusions (AP-Eph) to identify regions in the embryo expressing the ligand (the midbrain 
and anterior hindbrain). They then prepared cDNA libraries from those regions, 
expressed them in pools in COS cells, and identified appropriate clones that produced 
proteins which could bind AP-Eph (Cheng and Flanagan, 1994). Remarkably, the 
identified ligands (ephrins) were predicted to be membrane-bound proteins, as opposed to 
soluble growth factors. 
The size of the Eph/ephrin family continued to grow as related ligands and 
receptors were discovered. Currently, Ephs are divided into two classes based on their 
ligand binding (Lemke, 1997). The mammalian EphA family is comprised of 9 receptors 
(EphA1-EphA8, EphA10) and binds a set of glycosylphosphatidylinositol (GPI)-linked 
ligands, the ephrin-As (ephrinA1-A5) (Klein, 2009). The EphB class (EphB1-4, EphB6) 
preferentially binds a separate set of ligands, transmembrane proteins called ephrin-Bs 
(ephrin-B1-3) (Klein, 2009). These binding rules have some exceptions: EphA4 binds to 
ephrin-B2 and ephrin-B3 in addition to ephrin-As (Gale et al., 1996) and EphB2 binds to 
ephrin-A5 in addition to ephrin-Bs (Himanen et al., 2004). There might even be greater 
promiscuity in vivo, since most measurements to date have been made using soluble 
ephrins, which bind to the receptor in a three-dimensional reaction, whereas ligand-
receptor binding in vivo is essentially two-dimensional (Poliakov et al., 2004). 
The large Eph family of receptors shows a striking increase in complexity over 
evolution: C. elegans contain one Eph homologue, VAB-1 (George et al., 1998), as do 
Drosophila, Dek (Scully et al., 1999). It is reasonable to postulate that Ephs play a part in 
the evolution of the more complex mammalian nervous system and that the generic   8
structure of family members represents duplications throughout evolution (Drescher, 
2002). 
Since their ligands are membrane bound, Ephs are particularly well suited among 
RTKs to mediate short-range signaling and cell-cell contacts. This allows them to exert 
more localized influence than other RTKs (Toth et al., 2001). Ephs also have the ability 
to coordinate reciprocal communication between cells as both EphAs and EphBs can 
conduct bidirectional signaling by serving as ligands (to ephrins) in addition to serving as 
receptors (Holland et al., 1996; Lim et al., 2008b). 
  Ephs are expressed broadly during development and in the adult (Gale et al., 
1996). However, classically they were studied for their role in retinotectal mapping in the 
chick, where they mediate the projection of axons from the retina to the superior 
colliculus or tectum. A gradient of EphA expression in the retina causes pathfinding 
axons to locate the correct target area in the tectum based on a local repellant gradient of 
ephrin-As (Flanagan and Vanderhaeghen, 1998). 
 
The Structure of Ephs 
To achieve their many functions in nervous system development and beyond, 
Ephs have a complex domain structure that allows them to signal in multiple modalities 
(Figure 1.1). The extracellular region of Ephs consists of three major domains: the 
globular domain which is sufficient for ephrin binding, a cysteine rich region, and two 
fibronectin type III repeat domains which mediate protein-protein interactions (Labrador 
et al., 1997).   9
 
Figure 1.1: Structure of EphBs and their ligands ephrin-Bs 
The extracellular region of EphAs and EphBs contains a globular ephrin binding domain, 
a cysteine rich region, and two fibronectin type III repeat domains. The intracellular 
region of Ephs contains a juxtamembrane region, a kinase domain, a sterile-alpha motif 
(SAM) domain, and a PDZ-binding motif at the C-terminus. 
Both ephrin-As and ephrin-Bs contain a globular domain in their extracellular region. 
Ephrin-As are tethered to the plasma membrane via a GPI-linkage while ephrin-Bs span 
the membrane and contain an intracellular domain with a PDZ-binding motif at the C-
terminus.   10
 
Intracellularly, Ephs have three major regions: the juxtamembrane region is 
essential for regulating receptor activation (Wybenga-Groot et al., 2001). The kinase 
domain is responsible for catalytic activity. A sterile-alpha motif (SAM) domain 
regulates oligomerization (Thanos et al., 1999). Finally, a PDZ-binding motif at the C-
terminus mediates interactions with PDZ-domain containing proteins. 
The structure of ephrins is consistent with their ability to signal through multiple 
modalities as well. Ephrins have a globular domain which mediates ligand dimerization, 
as determined by crystal structures of an ephrin ectodomain (Toth et al., 2001). Ephrin-
As are tethered to the membrane via a GPI anchor. Ephrin-Bs have a short cytoplasmic 
region containing 5 conserved tyrosines and a C-terminal PDZ-binding motif (Kullander 
and Klein, 2002). 
Structural studies of ephrin binding to Eph show that the ligand-receptor 
interaction promotes higher order clustering (Himanen et al., 2001). Biochemical studies 
have demonstrated previously that only clustered ephrins activate Ephs (Davis et al., 
1994). In addition, a stoichiometry of 1:1 is predicted based on ephrin-A-EphA binding 
experiments (Lackmann et al., 1997). Thus ephrin/Eph signaling consists of the formation 
of large clusters on both the ephrin- and Eph-expressing cells that can serve as signaling 
centers at the plasma membrane. Researcher have taken advantage of this finding by 
generating ephrin or Eph peptides fused to the FC-region of IgG antibodies that can be 
easily clustered by addition of a secondary antibody. 
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Cell biology of Ephs 
Ephs regulate several key cellular processes. Broadly speaking, their activities fall 
into two opposite classes, adhesion and repulsion. This paradoxical duality of purpose 
seems to depend upon exact context. The question of what mediates this switch has 
stimulated several hypotheses, with groups postulating the essential determinant to be the 
density of ligand clustering (Poliakov et al., 2004), regulated endocytosis (Marston et al., 
2003; Zimmer et al., 2003), alternative splicing (Holmberg et al., 2000), and proteolytic 
cleavage (Hattori et al., 2000). 
During different phases of neuronal development, the cellular compartment of 
Eph expression varies, from generally axonal to majority dendritic (Henderson et al., 
2001). In the hippocampus, this contrast is seen most clearly with EphBs postsynaptic at 
Schaffer collateral synapses and presynaptic at mossy fiber synapses (Klein, 2009). 
 
The EphB family 
Of the two subclasses of Ephs, the EphBs present the most elaborate array of 
signaling capabilities due to the relative complexity of their ligands, the ephrin-Bs. 
EphBs play an important role in numerous aspects of nervous system development and 
have been studied extensively in this context. Of the five EphB receptors, EphB1-3 and 
EphB6 are expressed in neurons while EphB4 is expressed in blood vessels (Palmer and 
Klein, 2003). EphB6, a pseudokinase, has no catalytic kinase activity but can still engage 
in signaling, as it is required for proper T cell responses in vivo (Luo et al., 2004). 
EphB1, EphB2, and EphB3 are considered the catalytically-active EphB receptors 
in the brain and will be referred to as EphBs in this dissertation (Figure 1.2). They   12
mediate processes as diverse as axon guidance, topographic mapping, neuronal migration, 
and synapse formation (Genander and Frisen, 2010; Klein, 2004; Lai and Ip, 2009). 
 
 
 
 
Figure 1.2: Expression of EphBs and ephrin-Bs in cortical neurons 
Expression data from RNA sequencing experiments from 7 day in vitro (DIV) cultured 
cortical neurons. Figures were assembled from publicly available data published 
previously (Kim et al., 2010). Comparison of mRNA expression between genes is 
possible since quantification does not depend upon hybridization of probes as in qPCR or 
in situs. EphBs are expressed at moderate levels well above background (ROR1), but 
below the highly-expressed TrkB receptor. All 3 ephrin-Bs are expressed in cortical 
cultures. RPKM = reads per kilobase of exon model per million mapped reads.   13
In addition to these developmental roles, the ephb2 gene has been linked to autism 
spectrum disorder (Sanders et al., 2012) and EphB dysfunction in the mature organism is 
thought to contribute to pathologies such as Alzheimer’s Disease (Cisse et al., 2011). 
EphBs are highly pleiotropic and have been implicated in almost every step of 
nervous system development. Because of the interlocking nature of developmental stages, 
isolating the specific role of EphBs in individual processes has been exceedingly 
challenging. 
 
1.3 EphB receptor function in the developing nervous system 
EphBs and ephrin-Bs are often expressed in intricate patterns: one particularly 
prescient study investigated expression of EphB2 in the developing embryo and noted 
complementary/edge expression compared to ephrin-B2. The authors correctly 
hypothesized a role for EphBs in boundary formation (Gale et al., 1996). A later 
comprehensive in situ study in neonatal and adult mice revealed broad expression of 
EphBs and ephrin-Bs throughout the nervous system, including in the cortex, basal 
ganglia, hippocampus, hypothalamus, and midbrain (Liebl et al., 2003). This broad 
expression pattern is consistent with the numerous developmental roles assigned to the 
EphB receptors throughout the literature. 
 
Early patterning and differentiation 
EphBs have been linked to even the earliest stages of neural development. After 
the establishment of germ layers in the embryo, the nervous system arises out of the   14
ectoderm. Cells within the ectoderm are induced to form the neural plate (which will later 
give rise to the nervous system) by a group of mesodermal cells forming a transient 
structure called the notochord. Disruption of ephrin-B/EphB signaling by overexpression 
of dominant negative constructs in Zebrafish leads to defects in notochord development 
(Chan et al., 2001). 
  During the process of neurulation, the neural plate folds upon itself giving rise to 
the neural tube (which will form the central nervous system) and the outlying neural crest 
(which will form the peripheral nervous system). Even as early as embryonic day 10.5 
(E10.5), EphB2/EphB3 knockout mice have defects in neural tube formation, with an 
expanded ventral midline composed of cells destined to become the midbrain (Altick et 
al., 2005).  
The neural tube goes on to differentiate into disparate regions of the brain and 
spinal cord, while cells in the neural crest migrate extensively to the periphery. In EphB2 
knockout mice, this migration of neural crest cells is perturbed (Wang and Anderson, 
1997). Studies in the chick support this role (Krull et al., 1997; Santiago and Erickson, 
2002). 
After basic patterning, neural progenitors give rise to the cells that will populate 
the nervous system. Perturbing ephrin-B1 signaling causes premature differentiation of 
neural progenitors in the developing mouse embryo (Qiu et al., 2008), suggesting a role 
for EphB signaling in restricting this process. These newborn neurons then migrate to the 
correct cortical layers. In vitro studies and mouse developmental expression data suggest 
that EphBs are particularly important for the migration of cerebellar granule cells (Lu et 
al., 2001). Taken together, these reports of EphB involvement in the most basic processes   15
of neural development suggest that perturbation of EphBs in the embryo might have far 
reaching consequences in the juvenile or adult organism that originate from aberrant 
embryonic development.  
 
Neurite structure 
Once a neuron has been born and migrated, it soon polarizes and sprouts two 
types of processes: dendrites, which generally receive inputs, and axons, which transmit 
action potentials and ultimately release neurotransmitter. EphBs have been implicated in 
regulating the development of both of these fundamental structures. 
As dendrites grow, they often form elaborate branches on which to receive inputs. 
Cultured hippocampal neurons from EphB1/EphB2/EphB3 triple knockout (TKO) mice 
display decreased total dendritic length and complexity (Hoogenraad et al., 2005). In 
addition, a recent report found an increase in the number of primary dendrites in 
pyramidal neurons in slices from EphB1/EphB2 knockouts, consistent with a defect in 
dendritic pruning (Xu et al., 2011). 
Since the original identification of ephrin-A5 as a potent activator of growth cone 
collapse (Drescher et al., 1995), Ephs have been shown to mediate several functions in 
the growth cone. Ephrin-B2 binding to EphBs causes collapse of retinal ganglion cell 
(RGC) axon growth cones (Petros et al., 2010). In addition, EphBs regulate axon 
fasciculation, as EphB2/EphB3 knockout mice display abnormal bundling in the 
habenular-interpeduncular tract (Orioli et al., 1996) and hippocampal axon tracts (Chen et 
al., 2004). EphB TKO mice also exhibit defects in axon pruning, as hippocampal fibers   16
from these mice display increased infra-pyramidal bundle length of the mossy fiber, 
indicating the failure of some fibers to be properly eliminated (Xu and Henkemeyer, 
2009). 
  
Axon guidance 
In order for the intricate connections of the nervous system to form, neurons must 
send axons to specific target regions, sometimes up to distances of one meter in humans. 
Axon guidance throughout the nervous system, particularly across the midline, is heavily 
regulated by EphBs. The formation of the two main tracts that carry information between 
the hemispheres of the brain is controlled by EphB signaling: anterior commissure 
defects were observed in the original EphB2 knockout mouse (Henkemeyer et al., 1996). 
Additionally, corpus callosum defects were identified in an EphB2/EphB3 knockout 
mouse (Orioli et al., 1996). 
Several other regions display EphB-dependent axon guidance. In the spinal cord, 
commissural axons express EphBs and collapse in response to ephrin-Bs (Imondi et al., 
2000). EphB TKO mice have spinal cord commissural axon routing defects (Kadison et 
al., 2006), suggesting a role for EphBs in spinal midline guidance. EphBs have also been 
implicated in fine-tuning the guidance of lower motor neuron axons to their targets in the 
limbs (Luria et al., 2008). 
EphBs are important mediators of axon guidance in many of the sensory systems 
as well. In the visual system, studies using EphB1 and ephrin-B1/ephrin-B2 knockout 
mice show a role in forming the ipsilateral retinal projection to the lateral geniculate   17
nucleus (LGN) and superior colliculus (SC) (Chenaux and Henkemeyer, 2011; Williams 
et al., 2003). In the vestibular system, EphB2 knockout mice exhibit strain-specific 
circling behavior and have delayed midline crossing by inner ear efferents (Cowan et al., 
2000). In the auditory system, EphB1 and EphB3 knockout mice have defective hearing, 
consistent with a perturbation of axon guidance in the cochlea (Howard et al., 2003). 
These studies demonstrate the vital role for EphBs in axon guidance throughout the 
nervous system. 
 
Topographic mapping 
After axons have reached the proper brain region, they terminate in specific target 
areas. Many of the connections between brain regions preserve a map, often representing 
a sensory space. Thus, points that are close in space are represented by neurons that are in 
proximity. In the visual system, mapping of spaces in the visual field is achieved at 
several relay centers from the retina to the cortex. To achieve this retinotopy, comparable 
areas in different brain regions are often matched by gradients of guidance factors. There 
is a dorso-ventral gradient of EphB2 in the chick retina (Holash et al., 1997) and ephrin-
B2 in the chick tectum (Braisted et al., 1997) suggesting a role in retinotectal mapping. In 
Xenopus, perturbing ephrin-B/EphB signaling in vivo leads to defects in dorso-ventral 
topography of retinotectal axons (Mann et al., 2002). In mice, EphB2 and EphB3 are 
expressed in a dorso-ventral gradient in the retina while ephrin-B1 is expressed along a 
lateral-medial gradient in the superior colliculus (Hindges et al., 2002). Consequently, 
EphB2/EphB3 knockouts display defective retinocollicular mapping along this axis 
(Hindges et al., 2002).   18
 
Synapse formation 
As axons home in on their proper targeting field, they make contact with dendrites 
and begin the process of synaptogenesis. Electron microscopy studies have localized 
EphBs at synapses, and thus implicated them in the formation or function of synapses 
(Buchert et al., 1999). Early dominant negative data confirmed this role, as perturbing 
EphB2 function in cultured neurons led to fewer glutamate receptors on dendrites (Dalva 
et al., 2000) and alterations in the morphology and number of dendritic spines, the sites of 
excitatory synapses (Ethell et al., 2001). 
While dominant negative experiments can be difficult to interpret due to possible 
off-target effects, the report of an EphB1/EphB2/EphB3 triple knockout (TKO) mouse 
provided firm evidence that EphBs regulate synapse and spine development either 
directly or secondarily (Henkemeyer et al., 2003). Hippocampal neurons cultured from 
EphB TKO embryos display a striking lack of dendritic spines at 21 days in vitro (DIV). 
Instead, they exhibit long, thin filopodia on their dendrites. Remarkably, these neurons 
also display a complete absence of glutamate receptors at synapses as assessed by both 
western blot and immunocytochemistry for synaptic markers. In acute hippocampal slices 
from these mice, dendritic spine density and morphology are severely perturbed, although 
not as dramatically as in culture. Analysis of various genetic combinations identified 
EphB2 as the most relevant family member in synaptogensis, but EphB1 and EphB3 
contribute to the phenotypes as well. Indeed, the phenotypes of any double knockout 
combination are less severe than the triple knockout. While these findings supported the 
idea that EphBs are key regulators of synapse and spine development, the pleiotropic   19
nature of EphBs makes it difficult to isolate these defects as primarily synaptic, since 
earlier processes vital to cellular development may have been perturbed. 
  The question of the timing of EphB involvement in synaptogenesis was further 
addressed using RNAi (Kayser et al., 2008). Even though EphB2 knockouts lack synaptic 
defects, RNAi of EphB2 in cultured neurons appears to cause significant synaptic defects. 
Studies of varying time points identified 3-14 days in vitro (DIV) as the key window of 
synapse regulation by EphB2, as RNAi from 0-7 DIV and 14-21 DIV produced no loss of 
synapses as measured by immunocytochemistry of PSD-95 and vGlut colocalization. 
  Although EphB2 knockout mice do not display abnormalities in basal synaptic 
transmission, RNAi of EphB2 at 0 DIV leads to a large decrease in miniature excitatory 
postsynaptic current (EPSC) frequency, but not amplitude, at 10 DIV, suggesting that 
EphBs regulate the formation of functional synapses (Kayser et al., 2006). However, this 
experiment did not contain a rescue or discussion of recording parameters, and cell health 
may have been perturbed in the RNAi, but not empty vector control condition. 
The role of EphBs in promoting dendritic spine formation was supported by 
studies in which exogenous ephrin addition led to spine formation in cultured 
hippocampal neurons (Henkemeyer et al., 2003; Tolias et al., 2007). Sometimes, this 
effect required overexpression of EphB2 (Penzes et al., 2003). Surprisingly, application 
of clustered EphB2 also led to spine formation (Segura et al., 2007) suggesting that either 
multiple forms of ephrin-B/EphB signaling may regulate spine formation or that the 
application of clustered proteins may causes non-physiological spine formation under 
certain culture conditions. 
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Development in the adult 
  Many of the early processes that shape the nervous system reappear in repeated 
motifs at later stages in development and in the adult. This fascinating recapitulation of 
developmental pathways in the adult is challenging to study. Knockout mice may have 
defects in the mature animal that seem to be bona fide phenotypes, but are actually relics 
of earlier problems in development. EphBs have been implicated in a number of such 
processes in the adult that are reminiscent of their developmental roles. 
  Pathways involved in the formation of synapses and spines may be reactivated 
during plasticity. C. Elegans Eph mutants show defects in synaptic homeostasis in the 
neuromuscular junction (NMJ) (Frank et al., 2009). In Xenopus, retinotectal Long Term 
Potentiation (LTP) is perturbed when soluble unclustered ephrin-B and EphB are bath 
applied (Lim et al., 2008a). 
In mammals, EphB mutants have been studied in the context of LTP and Long 
term depression (LTD) in the hippocampus. EphB2 knockout mice display defects in 
LTP and LTD at the Schaffer Collateral (Grunwald et al., 2001; Henderson et al., 2001) 
and perforant pathway synapses (Henderson et al., 2001). Mossy fiber LTP was defective 
when EphB signaling was perturbed acutely using soluble blocking peptides, however the 
specificity of these peptides is difficult to assess (Contractor et al., 2002). 
Studies of ephrin-B knockout mice support this role in plasticity. EphrinB2 and 
ephrinB3 knockouts have defects in Schaffer Collateral LTP and LTD (Grunwald et al., 
2004). Ephrin-B3 mice have defects in mossy fiber LTP as well (Armstrong et al., 2006). 
These results suggest that multiple forms of hippocampal plasticity are compromised 
when ephrin-B/EphB signaling is perturbed. However, given the extensive role of EphBs   21
in regulating the development of the hippocampus, it is not clear whether these defects 
are primary, or rather a secondary result of defective cellular migration or morphology. 
  An even more striking example of developmental processes recapitulated in the 
adult is the proliferation of stem cells. Just as EphBs have been implicated in 
neurogenesis in the developing embryos, they have also been linked to neurogenesis of 
adult stem cells in the hippocampus. Perturbing ephrin-B signaling in the adult by 
perfusing soluble unclustered ephrin-B and EphB increases cell proliferation in the 
subventricular zone (SVZ)  (Conover et al., 2000). In support of this, ephrin-B3 knockout 
mice display an increase in SVZ cell proliferation in the adult (Ricard et al., 2006) and 
EphB1/EphB2 knockouts exhibit a decrease in the number of neural progenitors in the 
adult hippocampus (Chumley et al., 2007). 
  Sometimes developmental pathways are reactivated in response to cellular trauma. 
EphB2 has been linked to Schwann cell migration after nerve injury. Consequently, mice 
in which soluble blocking EphB2 peptides have been applied show impaired recovery 
from peripheral nerve injury (Parrinello et al., 2010). Similarly, EphB3 has been 
implicated in the recovery from retinal nerve injury (Liu et al., 2006). 
 
1.4 EphB receptor signaling 
  In order to mediate these disparate processes, EphBs utilize a number of signaling 
capacities including their tyrosine kinase activity, clustering of cellular proteins, 
scaffolding, and reverse signaling. 
 
   22
Kinase signaling of EphBs 
Like most RTKs, EphB1, EphB2, and EphB3 can engage in conventional forward 
signaling through their kinase domain. In their basal state, the catalytic domain of EphBs 
is autoinhibited by a highly conserved juxtamembrane region (Wybenga-Groot et al., 
2001). The binding of ephrin-B ligands to EphBs leads to receptor clustering and 
intermolecular autophosphorylation of conserved tyrosine residues in the juxtamembrane 
region and the activation segment of the kinase domain (Binns et al., 2000); the initial 
autophosphorylation is thought to be possible due to low-level intrinsic kinase activity of 
the receptor (Himanen et al., 2007). This phosphorylation event acts as a switch to relieve 
catalytic autoinhibition and greatly enhances the kinase activity of EphBs. In addition, 
phosphorylation of these juxtamembrane tyrosines can create an SH2-binding site which 
recruits SH2 domain containing proteins (Himanen et al., 2007; Holland et al., 1996). 
Once activated, EphBs can phosphorylate a number of downstream targets. 
Identification of these substrates can help elucidate the pathways mediating the effects of 
EphBs in the cell. A number of these substrates have been discovered using various 
mass-spectrometry techniques. One group used stable isotope labeling by amino acids in 
cell culture (SILAC) to look for changes in phospho-tyrosines after ephrin-B1 stimulation 
(Zhang et al., 2008). While this approach cannot differentiate between direct and indirect 
targets of EphBs, it was able to identify many of the previously studied targets and 
suggest hundreds more. 
A separate mass spectrometry approach also yielded a number of putative EphB 
targets spanning several cell biological families (Jorgensen et al., 2009). Inspection of the 
putative EphB substrates from these studies shows that they are often involved in   23
pathways regulating cytoplasmic kinases and monomeric GTP-ases. This finding is 
consistent with the role for EphBs in regulating the actin cytoskeleton. 
 
Other modes of forward signaling 
Engagement of ephrin-B with EphB can lead to separate modes of signaling in the 
EphB-expressing cell that are not directly linked to its kinase function. The extracellular 
domain of EphBs can recruit binding partners including subunits of the NMDA subtype 
of glutamate receptor (Dalva et al., 2000). This interaction can lead to modulation of 
calcium influx through the NMDA receptor and can alter the induction of genes in the 
nucleus (Takasu et al., 2002). Since the initial discovery of this NR1 interaction, EphBs 
have been implicated in more extensive interactions with excitatory amino acid receptors 
and their regulatory machinery (Calo et al., 2006). 
  In their cytoplasmic regions, EphBs contain a PDZ-domain binding motif. This 
allows them to bind and recruit a number of synaptic proteins that contain PDZ domains, 
such as GRIP1 (Torres et al., 1998) and Pick1 (Zhuang et al., 2010). Given their ability to 
form high-order multimers, EphBs have the potential to rapidly cluster PDZ proteins and 
coordinate synaptic functions. 
 
Reverse signaling 
A remarkable feature of EphBs is their ability to engage in reciprocal signaling 
with their ligands, the ephrin-Bs. The surprising discovery that exposure of ephrin-B1 to 
EphB2 could cause phosphorylation of ephrin-B1 opened the door to a new model of 
signaling (Holland et al., 1996). The conserved tail of ephrin-Bs contains 5 tyrosines, 3 of   24
which have been shown to be phosphorylated in vivo (Kalo et al., 2001). Phosphorylation 
of the cytoplasmic tail of ephrin-Bs results in the recruitment of SH2-domain containing 
proteins like Grb4 (Cowan and Henkemeyer, 2001; Palmer et al., 2002). Ephrin-Bs also 
contain a PDZ-binding motif at their C-terminus (Lin et al., 1999) and can recruit PDZ-
domain containing proteins like GRIP-1 (Bruckner et al., 1999). 
Reverse signaling remains mysterious in many regards. While there is controversy 
as to what terminates ephrin/Eph signaling, the less discussed question of what initiates 
this signaling is perhaps even more unclear. In some ways, the initiation of signaling is a 
chicken and egg scenario, since one cell must be activated first. For the case where two 
cells come into contact, such as during axon guidance, there is a clear time at which 
signaling might begin. However, more research is required to understand ephrin-B/EphB 
signaling initiation in other contexts where cells are already in stable contact. The 
interdependency of forward and reverse signaling also makes experimental manipulations 
challenging, since many perturbations intended to isolate one mode of signaling may 
affect other modes as well. 
 
1.5 Previous approaches to studying EphB signaling 
Experimental biology depends upon observation followed by gain- and loss-of-
function experiments with appropriate controls. The study of EphBs has progressed as a 
result of all three approaches, each with advantages and limitations. In the case of EphBs, 
these strategies sometimes produce conflicting results; it is therefore worthwhile 
considering the merits of each approach separately. 
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Observation 
In developmental biology, identifying where and when a protein is expressed can 
often indicate a large part of the protein’s function. One early study investigating the 
localization of ephrins and Ephs noted their reciprocal expression patterns and correctly 
postulated their role in patterning and boundary formation (Gale et al., 1996). The 
creation of a mouse expressing a lacZ-EphB2 fusion protein made more detailed study of 
EphB expression possible and further implicated EphBs in a variety of developmental 
contexts (Henkemeyer et al., 1996). In particular, the gradients of ephrins and Ephs in the 
visual system indicated a role for mapping of retinal axons, as postulated by Sperry in his 
chemoaffinity hypothesis (Flanagan and Vanderhaeghen, 1998). Finally, certain stimuli 
such as seizure have been shown to regulate the expression of EphBs in the adult brain 
(Bruckner et al., 1999). 
Relying on expression patterns, however, may be misleading. Many 
developmental proteins continue their expression in the adult nervous system, yet it is 
uncertain whether they serve a function there. Rather, they may represent developmental 
relics whose downregulation has not been selected for by evolution. 
A more complex and perhaps significant observation would be to identify the 
patterns of activation of EphBs in various contexts. While one study noted that EphBs 
can be activated in the adult brain, and thus may indeed serve a role there, more careful 
analysis is warranted (Grunwald et al., 2001). This might be accomplished by probing 
brain sections with an antibody that specifically recognizes activated or clustered EphBs. 
Finally, careful observation of cellular processes can indicate the mechanism by 
which EphBs function. For example, live imaging studies of pathfinding growth cones   26
lent important insights into how retinal axons identify guidance cues and make decisions 
(Mason and Wang, 1997). Live-imaging studies in cultured neurons have similarly 
attempted to understand how EphBs mediate synaptogenesis (Kayser et al., 2008). 
 
Gain-of-function 
Several gain-of-function approaches have been used to study EphBs. The addition 
of soluble clustered ephrins can activate EphBs and lead to biological effects. For 
example, the addition of clustered ephrin leads to the clustering of the NMDA Receptor 
subunit NR1 in dissociated cultures of cortical neurons (Dalva et al., 2000). This 
approach has even been used in vivo, as intrathecal injection of dimeric ephrin-B2 can 
lead to changes in thermal sensation in mice (Battaglia et al., 2003). 
Similarly, overexpression of EphBs in heterologous cells has been shown to 
promote synaptogenesis (Kayser et al., 2006). This is supported by overexpression 
experiments in neurons that show an increase in synapse number as assessed by 
colocalization of PSD-95 and synapsin (Margolis et al., 2010). However, the 
overexpression of PDZ-binding motif containing proteins like EphBs may be difficult to 
interpret, since at high levels they may recruit synaptic proteins with which they do not 
normally interact. 
Finally, EphB gain-of-function experiments can be performed using tissue/stripe 
assays to isolate EphB activity. For example, the response of EphB-expressing axons to 
different cues can be measured by allowing the axons to grow between stripes of 
substrates (Bush and Soriano, 2009). This approach has been vital for understanding 
many features of Eph-dependent axon guidance.   27
 
Genetic loss-of-function 
The earliest EphB loss-of-function experiments utilized knockout technology to 
genetically excise the EphB2 gene (Henkemeyer et al., 1996). Study of these knockout 
mice immediately implicated EphBs in axon guidance and several other processes. These 
conclusions were supported by the later generation of ephrin-B knockout mice (Davy et 
al., 2004; Twigg et al., 2004; Wieland et al., 2004). Since the knockout approach should 
completely remove the protein and have no off-target effects, it is especially useful. 
However, knockout mice have several shortcomings: they are hampered by compensation 
and pleiotropism, so that in some cases other genes may compensate for the loss of 
EphBs, and in other cases observed defects may be secondary to an earlier developmental 
defect causes by loss of EphBs (Henkemeyer et al., 2003). In addition, loss of EphBs can 
be lethal in several backgrounds, making these mice difficult to study. Finally, these 
knockouts are all-or-none and do not distinguish between different modes of EphB 
signaling. 
Some of these deficiencies are solved by knockin mice in which EphB or ephrin-
B mutants are engineered to replace genes at their endogenous loci. The EphB2 lacZ 
mouse expresses a fusion protein of a cytoplasmically-truncated EphB2 fused to lacZ. 
This mouse has been reported to lack EphB2 forward signaling, however its 
juxtamembrane tyrosines still become phosphorylated (Grunwald et al., 2001). Similar 
ephrin-B lacZ mice exist as well. Although these mice can help with domain analysis and 
have indeed been the main evidence for reverse signaling, they still have the major 
problem of compensation. In addition, the EphB2 lacZ mouse fails to distinguish kinase   28
activity from other modes of cytoplasmic signaling (Henkemeyer et al., 2003). In 
particular, since ephrin-B binding to EphBs induces the formation of EphB plasma 
membrane aggregates, it remains a likely possibility that EphB aggregation and 
scaffolding, in the absence of induction of EphB tyrosine kinase activity, mediates some 
of the biological effects of EphBs (Himanen et al., 2007). 
 
Transient loss-of-function 
The problems of compensation and pleiotropism in knockouts can be solved by 
using approaches with better temporal control. Dominant negative mutant proteins are 
one such approach. Mutant or truncated proteins are overexpressed so that they will 
inactivate endogenous protein signaling, often by sequestering endogenous signaling 
partners or preventing the normal trafficking or folding of the target protein. A kinase-
inactive form of EphB2 has been successfully overexpressed as a dominant negative. 
This presumably heterodimerizes with endogenous EphB2s and blocks their 
autophosphorylation. However, as with most dominant negatives, the precise mechanism 
is often unclear and may involve binding to PDZ-domain containing proteins. In addition, 
EphB2 dominant negative experiments require overexpression at levels far higher than 
those at which the endogenous proteins are expressed (Dalva et al., 2000; Ethell et al., 
2001). While this dominant negative approach can assist the identification of possible 
functions of EphBs, its use in rigorous experiments designed to test endogenous signaling 
is limited. 
While RNA interference (RNAi) constructs have been extensively used 
throughout neuroscience, they have not been widely used in the EphB field (Kayser et al.,   29
2006; Kayser et al., 2008; Parrinello et al., 2010). When used appropriately, RNAi can 
allow acute knockdown of genes. However, in the case of EphBs, knockdown is difficult 
to rescue since EphB overexpression has a synaptic phenotype. In addition, off-target 
effects, especially with sensitive assays measuring synapses, are a major problem. One 
study found that introduction of shRNA into neurons can trigger the loss of excitatory 
synapses and dendritic spines in a manner dependent upon the hairpin sequence, and not 
upon the target (Alvarez et al., 2006). Perhaps most confounding is the fact that shRNAs 
might have cell-health effects that are difficult to measure. We have performed 
preliminary studies using a published EphB2 RNAi (Kayser et al., 2006) that suggest this 
may indeed be the case. 
One final acute loss-of-function approach is the use of unclustered ephrin ligands 
and Eph extracellular domains to block endogenous ephrin-B/EphB signaling (Contractor 
et al., 2002). The approach is based upon the idea that these unclustered proteins can soak 
up ephrins and Ephs on the cell surface and prevent their multimerization, thus rendering 
them inactive. As a control, unclustered FC proteins are often applied. While convenient, 
these soluble proteins may affect other cell surface proteins, thus leading to off-target 
effects that are difficult to measure. In addition, unclustered ephrin-B binding to EphB 
may not only block reverse signaling, but may also engage the receptor in unnatural 
modes of forward signaling. 
 
Pharmacology 
Considering the limitations of these previous approaches, an ideal strategy would 
be the design of inhibitors that could acutely and selectively inhibit EphB signaling in   30
vivo. Several groups have screened potential inhibitors using a variety of lead compounds, 
but with limited success. In targeting RTKs, the major strategies are usually to block one 
of the following processes: ligand binding; receptor dimerization; autophosphorylation; 
recruitment of adaptor proteins; signaling cascades; internalization and nuclear 
translocation; and biosynthesis (Bennasroune et al., 2004). 
One group has developed the SNEW peptide, a 12-mer, which binds in the ligand-
binding site of EphB2 (Koolpe et al., 2005). The peptide blocks the binding of ephrin-B2 
to EphB2 at an IC50 of 15 μM (Chrencik et al., 2007) and blocks EphB activation at an 
IC50 of 100 μM (Noberini et al., 2012). As the IC50s suggest, this peptide has limited 
potency. 
Gray and colleagues have used a different approach to screen and identify more 
potent inhibitors based on the lead compound nilotinib that targets the kinase domain of 
EphBs. Several of their identified compounds inhibit EphB autophosphorylation at an 
IC50 of 40 nM (Choi et al., 2009). However, these compounds are not sufficiently 
selective and inhibit a range of other kinases including Frk, Kit, and Lck. 
One more group developed an assay to rapidly screen molecules that inhibit the 
kinase activity of EphB3 in vitro. An EphB3 peptide was incubated with the biotinylated 
tyrosine peptide substrate (BTK), biotin-AGAGLKKVVALY*DYMPM, where Y* 
denotes phosphorylation. After screening through a library of 120,000 small molecules 
for their ability to block BTK phosphorylation, they identified several potent inhibitors of 
EphB3 (Qiao et al., 2009). However, as with previous approaches, these were not 
sufficiently selective for mechanistic studies. 
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1.6 Summary of dissertation 
While EphBs have been implicated in almost every stage of neural development, 
for the most part it remains to be determined which cellular processes require EphB 
receptor tyrosine kinase activity, and which cellular responses are mediated by EphB 
tyrosine kinase-independent signaling events. Since the EphB family of receptors has 
been shown to regulate a large number of developmental processes, it has been 
particularly challenging to determine the specific functions of EphBs at defined times 
during brain development. The presence of at least three partially redundant EphB family 
members expressed in the nervous system complicates experiments further. For example, 
the EphB1, EphB2, and EphB3 single and compound knockout mice display defects in a 
number of processes including stem cell proliferation, axon guidance, filopodial motility, 
dendritic spine formation, synapse development, and long-term potentiation (LTP), but it 
is unclear which of these interdependent phenotypes are primary and which are secondary 
to the disruption of EphB signaling (Grunwald et al., 2001; Henderson et al., 2001; 
Henkemeyer et al., 1996; Kayser et al., 2008). 
Thus, new ways of selectively inhibiting specific functions of EphBs are needed 
to clarify the kinase-dependent and kinase-independent mechanisms by which EphBs 
control specific developmental events such as synapse formation and axon guidance. 
In chapter 2, we describe the development of a chemical-genetic approach to 
selectively and acutely inhibit EphB tyrosine kinase activity. We generated knockin mice 
and demonstrate the utility of this approach in neurons.   32
In chapter 3, we use these knockin mice to investigate the function of EphB 
tyrosine kinase activity in axon guidance. We inhibit kinase signaling in several contexts 
and demonstrate a requirement for EphB tyrosine kinase activity in retinal and cortical 
axon guidance in vivo. 
In chapter 4, we address the role of EphB tyrosine kinase signaling in synapse and 
dendritic spine development. Using dissociated neurons and organotypic slices from the 
knockin mice, we find that EphB tyrosine kinase signaling in not required for synaptic 
development.   33
Chapter 2 
A chemical-genetic approach to studying EphB 
signaling 
   34
2.1 Background 
Chemical-genetics 
Despite the great interest in targeting protein kinases, the development of potent 
and selective inhibitors has proven challenging (Bishop et al., 1998; Blethrow et al., 
2004). For small molecules which do successfully inhibit a kinase, there is no 
straightforward way to assess specificity in cell-based systems and in vivo. Indeed, many 
successful drugs in the clinic affect numerous targets in humans and their relevant 
mechanisms remain unclear. While this ambiguity may be acceptable in medicine, it is 
not suitable in the scientific investigation of basic biology. Even if selective inhibitors 
can be developed for in vitro use, their pharmacokinetic properties must be acceptable for 
use in vivo. 
To overcome these hurdles, a chemical-genetic strategy has been developed 
combining the advantages of pharmacology and genetics. Using this approach, drug-
sensitivity can be engineered into a protein, allowing for more controlled experimentation. 
This chemical-genetic technique was pioneered by Kevan Shokat and colleagues of the 
University of California, San Francisco. 
 
Analogue-sensitive kinase alleles (ASKA) 
In the 1990s, the laboratory of Kevan Shokat developed new methods of protein 
engineering to identify kinases that could accept unnatural ATP analogs. This approach 
aimed to uniquely label the substrates of a specific kinase and thus gain new insights into 
cell signaling. Based on available crystal structures of serine/threonine kinases, Shokat   35
and colleagues mutated Src at two sites and identified a mutation at residue 338 in the 
ATP-binding pocket that allowed the mutant Src to accept the ATP analog N
6-
(cyclopentyl)-ATP (Shah et al., 1997). While these mutant kinases could utilize new 
unnatural nucleotides (and thus facilitate labeling), they were also made sensitive to new 
synthetic inhibitors (Bishop et al., 1998). In fact, the investigators discovered that it was 
residue 338 that conferred the structural basis of Src inhibition by the previously used 
drug 4-Amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]- pyrimidine (PP1) (Figure 
2.1B) (Liu et al., 1999). 
This approach was soon generalized. The ATP-binding pocket of all kinases 
contains a bulky hydrophobic “gatekeeper” residue, amino acid 338 in Src. When 
mutated to an alanine or a glycine, the kinase can be rendered sensitive to inhibition by 
bulky PP1 analogs that cannot effectively enter the wild type ATP-binding pocket 
(Alaimo et al., 2001; Bishop et al., 1998). These are known as analog-sensitive (AS) 
kinases (Figure 2.1A, B). Importantly, these mutant kinases can still accept ATP in the 
absence of PP1 analogs. 
After its initial conception, this strategy was successfully used in heterologous 
cells (Bishop et al., 1998) and soon after in a budding yeast model (Bishop et al., 2000). 
Investigators were able to acutely inhibit cdc28 kinase function and isolate its roles in the 
cell cycle, altering time and dose to parse its function in vivo. 
In 2005, an analog-senstive knockin mouse was generated to study neurotrophin 
signaling in vivo (Chen et al., 2005). TrkA, TrkB, and TrkC were all successfully 
targeted and specific inhibition was achieved in vivo, as assessed through survival assays 
of the superior cervical ganglia (TrkA), nodose ganglia (TrkB), and dorsal root ganglia    36
 
 
Figure 2.1: Analog-sensitive kinases alleles (ASKA) 
(A) Schematic demonstrating the chemical-genetic strategy of targeted kinase inhibition. 
Analog-sensitive (AS) kinases contain a mutation in the ATP-binding pocket which does 
not alter normal kinase function (left). However, this mutation renders the AS kinases 
sensitive to competitive inhibition by PP1 analogs that cannot efficiently enter the ATP-
binding pocket of WT kinases (right). 
(B) Chemical structures of: 
 4-Amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]- pyrimidine (PP1) 
4-amino-1-tert-butyl-3-(1′naphthyl)pyrazolo[3,4-d]pyrimidine (1-NA-PP1) 
1-(tert-Butyl)-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (3-MB-PP1)   37
(TrkC). These mice were later used to address new questions in neurotrophin signaling, 
such as in isolating the spatial requirements of TrkA signaling on cell/dendrites as 
opposed to axons in regulating synaptic assembly in sympathetic neurons (Sharma et al., 
2010). 
We reasoned that this technology would be especially appropriate for the EphBs 
because of their pleiotropism and multiple signaling domains. 
 
2.2 EphB analog-sensitive kinases 
Generation of AS-EphBs kinases 
To determine the feasibility of generating AS-EphBs, we compared the amino 
acid sequence of kinase domains of EphBs with those of related tyrosine kinases for 
which AS versions had been successfully generated (Bishop et al., 2000; Chen et al., 
2005). This analysis revealed a conserved gatekeeper threonine residue in the ATP-
binding site of mouse EphB1, EphB2, and EphB3. Using DNA plasmids in the pcs2+ 
vector, we mutated these gatekeeper residues to either alanine or glycine to generate 
EphB1
T697G, EphB2
T699A, and EphB3
T706A AS receptors (Figure 2.2). 
 
Validation in heterologous cells 
To verify that the mutations introduced into the EphB ATP-binding sites did not 
affect the kinase activity of EphBs in the absence of the PP1 analogs, we assessed the 
activity of these kinases using a heterologous cell culture system. We previously    38
 
 
 
Figure 2.2: Sequence alignment of EphB kinase domains 
Amino acid alignment of kinase domains of mouse EphBs with those of Src and TrkB. 
The gatekeeper residue is highlighted in red and the drug-sensitive mutation (AS) in 
EphBs is shown on the right. 
 
 
 
generated an antibody that specifically recognizes the phosphorylated form of these 
juxtamembrane tyrosine residues for all EphBs and used these anti-phospho-EphB 
antibodies as a readout for receptor kinase activity (Dalva et al., 2000). In order to study 
EphB autophosphorylation without the need for ligand application, we overexpressed the 
receptors in Human Embryonic Kidney (HEK) 293 cells where EphBs cluster 
spontaneously and are activated even in the absence of ligand. 
We probed lysates from cells overexpressing AS-EphBs or WT EphBs with the 
anti-phospho-EphB antibody, and found that WT and AS-EphB receptors are 
phosphorylated at their juxtamembrane tyrosines to a similar extent (Figure 2.3A). This   39
indicates that the AS mutation does not affect the ability of EphBs to activate their kinase 
domains in the absence of PP1 analogs. 
 
 
 
 
 
Figure 2.3: Rapid, reversible, and selective inhibition of AS EphBs 
(A) Inhibition of the kinase function of heterologously expressed EphB1, EphB2, and 
EphB3 in HEK 293 cells. EphB-expressing cells were incubated in 1-NA-PP1 (250 nM) 
or 3-MB-PP1 (1 μM) for 1 hour before lysis in SDS sample buffer, followed by western 
blotting for total EphB levels or auto-phosphorylated EphBs to assess kinase activation. 
(B) Time course of EphB1 inhibition in minutes after 1-NA-PP1 (250 nM) addition to 
EphB1-expressing HEK 293 cells. 
(C) Time course of recovery of EphB1 autophosphorylation in minutes after 1-NA-PP1 
(250 nM) washout from EphB1-expressing HEK 293 cells. The zero time point reflects 
the removal of 1-NA-PP1 after an initial 1 hour incubation.   40
 
To test the ability of PP1 analogs to inhibit AS-EphBs, we treated cells 
overexpressing AS-EphBs or wild type EphBs with the bulky PP1 analog 4-amino-1-tert-
butyl-3-(1′naphthyl)pyrazolo[3,4-d]pyrimidine (1-NA-PP1) (Figure 2.1B) and assessed 
EphB tyrosine autophosphorylation. We found that incubation with 1-NA-PP1 (250nM) 
blocked the phosphorylation of AS-EphBs but not the phosphorylation of WT EphBs 
(Figure 2.3A). Subsequent screening through a range of other inhibitors identified the 
PP1 analog 1-(tert-Butyl)-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (3-
MB-PP1) (Figure 2.1B) as another potent and selective inhibitor of AS-EphBs (Figure 
2.3A). 
The PP1-derivates were designed for cell permeability. To test how rapidly we 
could inhibit EphB autophosphorylation, we added inhibitor for increasing lengths of 
time before lysing cells. We found that inhibition of kinase activity of AS-EphBs was 
acute, occurring within minutes (Figure 2.3B). Inhibition was rapidly reversible upon 
removal of 1-NA-PP1, with autophosphorylation resuming within minutes (Figure 2.3C). 
These properties make the inhibitors ideal for studying dynamic processes in cells. 
To quantify the potency and specificity of 1-NA-PP1 and 3-MB-PP1 with respect 
to inhibition of each EphB, we generated dose-response curves ranging four orders of 
magnitude from 5nM to 21uM (Figure 2.4A, B). Western blots were quantified and plots 
were fitted with a standard Hill coefficient of -1. IC50s were calculated and revealed a 
preference for inhibiting AS kinases (9-48 nM) over WT kinases (0.6-8.9 µM) by two 
orders of magnitude. (Figure 2.4A, B). These results indicate that the kinase activity of 
AS-EphBs is selectively inhibited by PP1 analogs.   41
 
Figure 2.4: Dose-response curves of EphB inhibition after treatment with PP1 
derivatives 
(A) Dose response curves from inhibition of EphBs with 1-NA-PP1 in HEK 293 cells. 
Curves were fitting from 6-7 quantitative western blot data points using the least-squares 
method with a Hill coefficient of -1. The following R
2 values describe the fitting to derive 
IC50 values: EphB1 AS (0.99), EphB1 WT (0.98), EphB2 AS (0.96), EphB2 WT (0.98), 
EphB3 AS (0.99), EphB3 WT (0.99).   42
 
 
Figure 2.4 (continued) 
(B) Dose response curves from inhibition of EphBs with 3-MB-PP1 in HEK 293 cells. 
The following R
2 values describe the least-squares fitting to derive IC50 values: EphB1 
AS (0.99), EphB1 WT (0.94), EphB2 AS (0.996), EphB2 WT (0.99), EphB3 AS (0.998), 
EphB3 WT (0.97). 
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2.3 Generation of AS-EphB TKI mice 
Mouse genetics 
Based on these initial experiments, we designed knockin mice harboring the 
gatekeeper point mutation in EphB1 (T697G), EphB2 (T699A), and EphB3 (T706A), the 
three neuronally expressed EphB receptor tyrosine kinases. Targeting vectors were 
designed against exon 11 of chromosome 9 for EphB1 (Figure 2.5A), exon 11 of 
chromosome 4 for EphB2 (Figure 2.5B), and exon 11 of chromosome 16 for EphB3 
(Figure 2.5C). Blastocysts injections yielded chimeras which were mated to C57Bl/6 
WT mice. Subsequent breeding of knockin mice was validated by direct sequencing for 
the AS mutation (Figure 2.6A) and by PCR amplification to detect the presence of the 
loxP site (Figure 2.6B). 
Previous studies investigating neural progenitor proliferation and dendritic spine 
development have demonstrated the redundancy of EphBs in several contexts (Chumley 
et al., 2007; Henkemeyer et al., 2003). To overcome potential functional compensation 
by different EphB family members, heterozygote F1 offspring of EphB1
T697G, 
EphB2
T699A, and EphB3
T706A single mutant mice were intercrossed for several 
generations to produce homozygous triple knockin mice, designated EphB-analog 
sensitive triple knockin (AS-EphB TKI) mice (Figure 2.6C). 
Whereas EphB1/EphB2/EphB3 triple knockout (TKO) mice suffer from profound 
developmental defects including numerous morphological abnormalities (Risley et al., 
2009; Yucel et al., 2007), AS-EphB TKI mice develop normally into healthy, fertile 
adults, indistinguishable from WT mice.   44
 
Figure 2.5: AS-EphB KI mouse targeting strategy 
(A) Targeting strategy for generation of the analog-sensitive (AS) mutation in exon 11 of 
the ephb1 gene located on chromosome 9. 
* denotes the AS mutation 
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Figure 2.5 (continued) 
(B) Targeting strategy for generation of the analog-sensitive (AS) mutation in exon 11 of 
the ephb2 gene located on chromosome 4.  
* denotes the AS mutation 
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Figure 2.5 (continued) 
(C) Targeting strategy for generation of the analog-sensitive (AS) mutation in exon 11 of 
the ephb3 gene located on chromosome 16. 
* denotes the AS mutation   47
 
Figure 2.6: Validation of the AS mutation in AS-EphB TKI mice 
(A) Sequencing reads from EphB-AS TKI mice showing the gatekeeper (AS) mutation in 
the ephb1, ephb2, and ephb3 genes. 
(B) Genotyping PCR showing the presence of a novel band in DNA from AS-EphB TKI 
mice reflecting the insertion of a loxP site. 
(C) Breeding strategy to obtain AS-EphB TKI mice from single heterozygote mutants.   48
For example, anogenital defects in EphB TKOs are not observed in AS-EphB TKI mice. 
AS-EphB TKI brains exhibit normal morphology and are of equal size to WT mouse 
brains. In vitro assays measuring axon guidance, neuronal morphology, and synaptic 
development revealed no differences between WT and AS-EphB TKI mice (shown 
below), suggesting that AS-EphBs function normally in the absence of PP1 analogs. 
 
EphB-AS TKI mice are normal in the absence of PP1 derivatives 
Critical to the interpretation of experiments comparing wild-type and AS-EphB 
TKI mice is evidence that EphB mRNA expression and ligand-mediated receptor 
activation occur normally in AS-EphB TKI neurons in the absence of PP1 analogues. To 
assess whether EphB gene expression was affected by the gatekeeper residue mutations 
or the residual loxP sites that were introduced during generation of the mice, we 
performed quantitative PCR (qPCR) to measure expression of EphB1, EphB2, and 
EphB3 in neurons from WT and AS-EphB TKI mice. We found that the mutant alleles 
were expressed at the same levels as WT (Figure 2.7A). We conclude that the gene 
targeting did not affect the levels of EphB1, EphB2, or EphB3 mRNA expression in AS-
EphB TKI neurons.   49
 
Figure 2.7: Normal EphB expression and surface localization in AS-EphB TKI mice 
(A) Relative mRNA expression of EphB1, EphB2, and EphB3 normalized to β-actin in 
AS-EphB TKI vs. WT cultured cortical neurons at 7DIV. Data are mean ± SEM. 
(B) Surface expression of EphB2 at 12 DIV in cultured cortical neurons after treatment 
with vehicle or 1 μM 1-NA-PP1 from 6-12 DIV. Surface EphB2 was isolated by treating 
cells with sulfo-NHS-biotin, immunoprecipitating EphB2, and probing eluates with 
fluorescent streptavidin. 
 
We reasoned that receptor trafficking and internalization might be perturbed by 
the AS mutation or the inhibition of EphB tyrosine kinase activity. We performed surface 
biotin labeling for the EphB2 receptor after chronic inhibition from 6-12 days in vitro 
(DIV) in cortical neurons. We found equivalent levels of labeled EphB2 in vehicle and 1-
NA-PP1 (1 µM)-treated cells (Figure 2.7B). This result indicates that EphBs can 
properly traffic to the cell surface in AS-EphB TKI neurons in the presence of PP1 
analogs. 
The analog-sensitive kinase approach is designed to block EphB tyrosine kinase 
function and leave other signaling modalities intact. The clustering off EphBs allows 
them to serve as scaffolds and is thought to be kinase-independent. To test whether   50
inhibiting the tyrosine kinase activity of EphBs affected their higher-ordered clustering, 
cultured cortical neurons were stimulated with ephrin-B1, fixed, and stained with 
antibodies for EphB2. Large puncta were observable by 30 minutes and increased in 
number by 60 minutes. These were not seen after stimulation with clustered FC or after 
stimulation with ephrin-B1 and replacement of anti-EphB2 with a rabbit IgG. After 
inhibition with 1-NA-PP1 (250 nM) or 3-MB-PP1 (1 μM), EphB2 still formed large 
clusters, suggesting that high-order receptor oligomerization does not rely on the kinase 
signaling of EphBs (Figure 2.8). We therefore conclude that EphBs should be able to 
cluster cytoplasmic proteins via kinase-independent mechanisms. 
 
 
Figure 2.8: EphB clustering persists in the absence of EphB tyrosine kinase activity 
1 DIV cortical neurons were treated with vehicle, 250 nM 1-NA-PP1, or 1 μM 3-MB-PP1 
for 1 hour before a 60 minute ephrin-B1 stimulation. Cells were fixed, blocked, and 
stained for MAP-2 and EphB2. Data represent the number of EphB2 clusters per unit area. 
N=11-16 fields of view (63x) per condition.   51
We next asked whether neurons from AS-EphB TKI mice could engage in normal 
ephrin ligand-mediated tyrosine kinase signaling in the absence of PP1 derivatives. We 
cultured dissociated cortical neurons from embryonic AS-EphB TKI or WT mice and 
stimulated the neurons with clustered ephrin-B1 for 30 minutes. Western blotting of AS-
EphB TKI or WT lysates with phospho-EphB antibodies revealed that both WT and AS-
EphB TKI neurons exhibited robust EphB activation to similar levels, thus indicating that 
AS EphBs are fully competent to engage in kinase signaling in the absence of PP1 
analogs (Figure 2.9A). 
 
EphB tyrosine kinase signaling is blocked by PP1 derivatives in EphB-AS TKI mice 
To test whether the kinase function of EphBs from AS-EphB TKI mice is potently 
and selectively inhibited by PP1 analogs, we pretreated cultured neurons with vehicle 
(DMSO) or PP1 analogs for 1 hour before ephrin-B1 stimulation. Treatment with 250 nM 
1-NA-PP1 or 1 μM 3-MB-PP1 completely blocked ephrin-B induced EphB activation in 
the AS-EphB TKI, but not WT neurons (Figure 2.9A), thus demonstrating the efficacy 
and selectivity of these PP1 analogs in AS-EphB TKI neurons. 
To more rigorously test the selectivity of these inhibitors, we assessed the effect 
of inhiitors on EphA signaling. Cortical neurons from WT mice were pretreated with 250 
nM 1-NA-PP1 or 1 μM 3-MB-PP1 and stimulated with ephrin-A1 for 30 minutes. 
Lysates were immunoprecipitated with antibodies against EphA4 and probed for 
phospho-Eph or total EphA4. We found no inhibition of EphA4 autophosphorylation at 
doses of PP1 derivatives that fully block EphB tyrosine kinase function (Figure 2.9B),   52
 
 
Figure 2.9: Selective inhibition of EphBs, but not EphAs, in AS-EphB TKI neurons 
(A) 15 DIV cortical neurons were treated with vehicle, 250 nM 1-NA-PP1, or 1 μM 3-
MB-PP1 for 1 hour before a 30 minute ephrin-B1 stimulation. Lysates were blotted for 
phospho-EphB or β-actin. 
(B) 4 DIV cortical neurons were treated with vehicle, 250 nM 1-NA-PP1, or 1 μM 3-MB-
PP1 for 1 hour before a 30 minute ephrin-A1 stimulation. Lysates were 
immunoprecipitated with anti-EphA4 antibodies and blotted for EphA4 and phospho-Eph. 
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indicating that EphA tyrosine kinase signaling remains unperturbed even when EphB 
tyrosine kinase signaling is blocked. The specificity of AS inhibition between Eph family 
members contrasts with previous attempts at designing selective inhibitors for EphBs. 
Kinase cascades can amplify signals greatly, making inhibition of downstream 
pathways difficult. To test whether inhibition of the kinase activity of EphBs effectively 
blocks the phosphorylation of substrates, we studied phosphorylation of the well-
characterized Eph substrate Vav2, a Rho family guanine nucleotide exchange factor 
(GEF) that mediates growth cone collapse (Cowan et al., 2005). WT or AS-EphB TKI 
neurons were incubated in 1-NA-PP1 (250 nM) or 3-MB-PP1 (1 μM) and stimulated with 
ephrin-B1 for 30 minutes to induce Vav2 tyrosine phosphorylation. Immunoprecipitation 
of Vav2 followed by western blotting with a pan-phosphotyrosine antibody showed a 2- 
to 3-fold increase in tyrosine phosphorylation of Vav2 after ephrin-B1 stimulation 
(Figure 2.10A, B). Treatment with 1-NA-PP1 (250 nM) or 3-MB-PP1 (1 μM) selectively 
blocked the increase in p-Vav2 in AS-EphB TKI cells, but had no effect in WT cells 
(Figure 2.10A, B). We conclude that PP1 analogs can selectively block the kinase 
signaling of EphBs and the phosphorylation of their substrates in AS-EphB TKI cells.   54
 
Figure 2.10: PP1 derivatives block the phosphorylation of EphB substrates in AS-
EphB TKI neurons 
 
(A) 4 DIV cortical neurons were treated with vehicle, 250 nM 1-NA-PP1, or 1 μM 3-MB-
PP1 for 1 hour before a 30 minute ephrin-B1 stimulation. Lysates were 
immunoprecipitated with anti-Vav2 antibodies, and blotted with pan-phosphotyrosine 
(py99) or total Vav2 antibodies. 
(B) Quantification of phospho-Vav2 / Vav2 band intensity from quantitative western 
blots in (A). Graph represents mean ± SEM (n=3). Values were normalized to the 
unstimulated AS-EphB TKI vehicle-treated condition.   55
 
2.4 Discussion 
We have generated the first mice in which it is possible to conditionally block 
EphB tyrosine kinase signaling. Our chemical-genetic approach offers several advantages 
over conventional genetic loss-of-function studies (Knight and Shokat, 2007); these 
advantages are particularly relevant for studying EphBs given the multitude of 
mechanisms used by EphBs to regulate nervous system development. Since we are able 
to block the kinase activity of EphBs while leaving their scaffolding and reverse 
signaling capabilities intact, it is possible to dissect the role of the kinase activity of 
EphBs in vivo under conditions where EphBs are expressed at their normal levels. In 
addition, acute AS-EphB inhibition can circumvent the problem of developmental 
compensation that sometimes occurs after genetic lesions. As there are no conditional 
EphB1/EphB2/EphB3 mice yet available, the AS-EphB TKI mice will provide an 
appealing and in some ways more informative alternative for many experiments. 
Additionally, the reversibility of AS EphB inhibition should allow for temporal control in 
experiments investigating synaptic plasticity and behavior. 
The analog sensitivity of AS-EphB TKI mice should make it possible to 
determine in greater detail which of the many defects observed in EphB triple knockout 
mice are a direct consequence of the loss of the tyrosine kinase activity of EphBs and 
which defects are due to a loss of kinase-independent signaling. Finally, unlike 
conventional pharmacology, the AS-EphB knockin approach makes it possible to control 
for off-target effects of the PP1 analogs: each experiment can compare the effects of the 
inhibitors in AS-EphB TKI mice with those seen in WT mice which are identical except 
for the gatekeeper mutations within the ATP-binding sites of EphBs.   56
This chemical-genetic approach also has some disadvantages. Certain in vivo 
systems may be difficult to access with the inhibitors, as methods of drug delivery to the 
nervous system are often not trivial. In addition, the specificity for inhibiting tyrosine 
kinase signaling is useful, but it cannot distinguish other modes of signaling, such as 
reverse or scaffolding, from each other. Finally, a problem inherent to all EphB loss-of-
function approaches is that perturbing the kinase signaling may affect other aspects of 
EphBs. While this cannot be completely determined, since effects may be small or 
difficult to measure, it is important to keep in mind when drawing conclusions. 
Our experiments indicate that the doses of 1-NA-PP1 (250 nM) and 3-MB-PP1 (1 
µM) that we are using are relatively specific. Although it is not practical to screen 
through all kinases for off-target effects in our AS-EphB TKI mice, a study by Bain et al. 
has used an in vitro system to test the specificity of 1-NA-PP1 on other kinases using 
robotic screens. They found only two kinases, RIP2 and CKI, with IC 50s for 1-NA-PP1 
below 250 nM; however, both IC50s were still significantly higher than for the AS-EphB 
kinases (Bain et al., 2007). Although these data suggest that 1-NA-PP1 is highly selective 
for EphBs in AS-EphB TKI cells, WT controls can still be used in every experiment to 
control for off-target effects. 
Even with WT controls, it is possible that 1-NA-PP1 and 3-MB-PP1 inhibit other 
kinases to a small degree, thus creating a sensitizing background for certain readouts 
(Bain et al., 2007). Thus, it is not strictly possible to conclude that inhibiting EphB 
tyrosine kinase function is sufficient to cause any phenotypes detected (since dozens of 
other kinases may be slightly inhibited and promote a phenotype), but it is possible to 
conclude that EphB tyrosine kinase signaling is required. These limitations are well   57
within the scope of what might be expected for a novel technique, and still offer 
significant advantages over previous approaches. 
 
2.5 Materials and methods 
Generation of AS-EphB TKI mice 
EphB1
T697G, EphB2
T699A, and EphB3
T706A single mutants were generated 
individually by homologous recombination in mouse embryonic stem (ES) cells.  Mice 
harboring each of the KI mutations were then bred together through > 3 generations to 
obtain the triple homozygous AS-EphB TKI mice (Figure 2.6C). 
To facilitate the construction of three targeting constructs for modifying each of 
EphB1, EphB2 and EphB3 loci, a general purpose knockin vector (pKSNeoDTAIII) was 
first built from pKSNeoDTA (originally constructed in the lab of Philippe Soriano) to 
contain the following features:  a first multiple cloning site containing NotI, FseI and 
HindIII sites (for inserting the 5’ homologous arm), a loxP-PGK-Neo-loxP cassette for 
positive selection of ES cell clones, followed by a second multiple cloning site containing 
AscI, PacI, EcoRV and EcoRI sites (for inserting the 3’ homologous arm), and finally a 
diptheria toxin A negative-selection cassette (DTA).  The pKSNeoDTAIII vector was 
used to construct all three EphB KI targeting vectors (Figure 2.6A).   
To generate the EphB1 targeting construct, the 2.1 Kb 5’ arm was PCR amplified 
from J1 ES cell genomic DNA using a two-step PCR procedure. In the first step, primers 
EphB1-5outer-F and EphB1-5outer-R (Table 2.1) were used to enrich the target sequence 
using the Expand Long Template PCR system (Roche) for 15 cycles. The low number of 
cycles was designed to minimize the introduction of mutations. The product from this   58
first-step PCR, which was in an insufficient quantity to be visualized on an ethidium 
bromide-stained agarose gel, was column purified and used as template in the second-
step, nested PCR (primers EphB1-5F-Not and EphB1-5R-Fse) using the high fidelity 
DNA polymerase PFU for 25 cycles. The product was then subcloned into the first 
multiple cloning site of pKSNeoDTAIII through the NotI and FseI sites. The 4 Kb 3’ arm 
was similarly amplified using primers EphB1-3outer-F and EphB1-3outer-R in the first-
step PCR and primers EphB1-3F-Asc and EphB1-3R-Pac in the second nested PCR 
reaction. The 3’ arm was subcloned into pKSNeoDTAIII through the AscI and PacI sites.   
The EphB1 gatekeeper mutation was introduced by QuickChange (Strategene) site-
directed mutagenesis. The final targeting construct was confirmed by direct sequencing.   59
 
PRIMER NAME  PRIMER SEQUENCE  PURPOSE 
EphB1-5outer-F  GCATCCTTATGTGTGGGTGGG  1st step PCR for EphB1 5' arm 
EphB1-5outer-R  TCATTTACTGTGGCCCTCCCC  1st step PCR for EphB1 5' arm 
EphB1-3outer-F  TAAGAGCCACAGGGTTGTGGG  1st step PCR for EphB1 3' arm 
EphB1-3outer-R CCCACTAAAGCCCTCACTCAC  1st step PCR for EphB1 3' arm 
EphB1-5F-Not  GATCGCGGCCGCTTTGGGTGACACAGTGTCAG
GGTC 
2nd step, nested PCR of EphB1 5 
'arm 
EphB1-5R-Fse  GATCGGCCGGCCTCATGGTGGCAGGGAGGGAG
TTCC 
2nd step, nested PCR of EphB1 5' 
arm 
EphB1-3F-Asc  GATCGGCGCGCCGACATTCCCTCTTCCTTGTTA
GCG 
2nd step, nested PCR of EphB1 3' 
arm 
EphB1-3R-Pac  GATCTTAATTAATAGACCAGGTATCGCTATAG
CTTCTGGG 
2nd step, nested PCR of EphB1 3' 
arm 
    
EphB2-3581  CAGAAGCAGGCAGATCTCTGG  1st step PCR for EphB2 5' arm 
EphB2-2R GTCTCTTAGGGCTGCTCTGAC  1st step PCR for EphB2 5' arm 
EphB2-2F  CCCCAAACCCCAATGTTGGG  1st step PCR for EphB2 3' arm 
EphB2-6R CTGGTGTAGTCCGGTATCGTG  1st step PCR for EphB2 3' arm 
EphB2-5armU-Not GCGGCCGCTCCAGCTTCCAGCTTCCTGGGATG  2nd step, nested PCR of EphB2 5' 
arm 
EphB2-5armL-Hind GAAGCTTCCAGGGAACCACATTGAGAAGAAC  2nd step, nested PCR of EphB2 5' 
arm 
EphB2-3armU-Asc-ex  GAGGCGCGCCGAAACCTGAGCATTTCCTCAGG
G 
2nd step, nested PCR of EphB2 3 
'arm 
EphB2-3armL-Pac-ex GATCTTAATTAATGAGGTGCAGCAGGGAGAAG  2nd step, nested PCR of EphB2 3' 
arm 
    
EphB3-5outer-F TCTTCCTGTCCTCGCCTCTG  1st step PCR for EphB3 5' arm 
EphB3-5outer-R ATGCAGGGACCAGCCAGATTG  1st step PCR for EphB3 5' arm 
EphB3-3outer-F GGAGGGTCCTAAACAGCAGG  1st step PCR for EphB3 3' arm 
EphB3-3outer-R  TTGGTGAAGGGACCCAGGAG  1st step PCR for EphB3 3' arm 
EphB3-5F-Not AGGTGCGGCCGCGAACAGGAGTCGTGTTGCCC  2nd step, nested PCR of EphB3 5' 
arm 
EphB3-5R-Fse  AGGTGGCCGGCCCCCGTGTTCCTGGAACAATA
TGTC 
2nd step, nested PCR of EphB3 5' 
arm 
EphB3-3F-Asc  AGGTGGCGCGCCGCAGCTGGGTGAGAAAAGT
GCAGAG 
2nd step, nested PCR of EphB3 3' 
arm 
EphB3-3R-Pac AGGTTTAATTAACTGCCCGCTTCTGTTTGTTGG  2nd step, nested PCR of EphB3 3' 
arm 
    
EphB1-2398 CATCATTCGCCTGGAGGGTGTCG  Genotyping of EphB1 KI allele 
EphB1gt-5R-1 CCTCCCTGCATTCCTCACTC  Genotyping of EphB1 KI allele 
EphB2cre_GT_F1 CAGTTCGACCACCCCAATGTC  Genotyping of EphB2 KI allele 
EphB2cre_GT_R1 GCACCTCAGGCAGCATAACC  Genotyping of EphB2 KI allele 
EphB3-3outer-F GGAGGGTCCTAAACAGCAGG  Genotyping of EphB3 KI allele 
EphB3-5outer-R ATGCAGGGACCAGCCAGATTG Genotyping  of EphB3 KI allele 
 
Table 2.1: Primers used in the generation of AS-EphB TKI mice.   60
 
To target the EphB1 locus in ES cells, the targeting construct was linearized with 
NotI restriction enzyme and electroporated into J1 ES cells, which were subsequently 
selected with G418. Surviving colonies were picked and genotyped for correct 
recombination of both 5’ and 3’ arms by PCR. The correct targeting events were further 
confirmed by Southern analysis using probes that anneal to EphB1 genomic regions 
outside of the homologous arms, and by direct sequencing of PCR products amplified 
from the mutated allele. The positive clones were karyotyped for gross chromosomal 
abnormality. The Neo cassette was removed by electroporating targeted ES cells with a 
Cre expression plasmid. Individual clones were picked again, genotyped for the loss of 
the Neo cassette and karyotyped. The final selected ES clones were microinjected into 
C57BL/6 blastocysts to generate chimeric mice. Male chimeric animals with high-
percentage aguti coat color were mated to C57BL/6 wild-type females, and aguti 
offsprings were genotyped for germline transmission of the targeted allele.   
The EphB2 and EphB3 KI mice were similarly generated (Figure 2.6B, C). The 
primers used in the two-step PCR reactions to subclone the targeting arms of EphB2KI 
and EphB3KI targeting vectors are listed in Table 2.1. The ES cell targeting efficiencies 
were as follows: EphB1 KI (17/192 = 9%), EphB2 KI (3/186 = 2%), EphB3 KI (12/96 = 
13%). 
Mice were maintained as homozygotes in a mixed 129/C57BL/6 background. 
Unless noted, wild-type (WT) mice were F1 offspring of a C57BL/6 x129sv cross.   61
All experiments with mice were approved by the Animal Care and Use 
Committee of Harvard Medical School. Embryonic day 0 (E0) was defined as midnight 
preceding the morning a vaginal plug was found. 
 
HEK 293 cell culture and transfection 
HEK 293 cells were maintained in DMEM supplemented with 10% fetal bovine 
serum (Gibco), 2mM glutamine (Gibco), and penicillin/streptomycin (100 U/mL and 100 
μg/mL, respectively; Gibco). HEK 293 cells were transfected for 24 hours using the 
calcium phosphate method as previously described (Lois et al., 2002). For experiments 
using overexpressed EphB receptors, 0.15ug of pcs2+-based EphB plasmids were 
transfected into 2x10
^5 cells in one well of a 24-well plate. 
 
Western blotting 
Lysates were prepared in 1x SDS-sample buffer (50 mM Tris pH 6.8, 2% SDS, 
10% glycerol, 0.1% Bromphenol Blue, 5% β-mercaptoethanol). Western blots were 
probed with the following antibodies: rabbit anti-EphB1 (H-80, Santa Cruz); rabbit anti-
EphB3 (H-85, Santa Cruz); rabbit anti-EphB2 (generated in the Greenberg lab and 
described previously (Dalva et al., 2000)); rabbit anti-pan-phospho-Eph (generated in the 
Greenberg lab and described previously (Dalva et al., 2000)). The anti-pan-phospho-Eph 
was generated from the peptide CLRTY
*VDPHRY
*EDPTQ of EphA3, where Y
* denotes 
phosphorylation. The phospho-specificity of the antibody was validated in HEK 293 cells 
for EphB1, EphB2, and EphB3 individually. For probing lysates in neurons or for   62
immunocytochemistry, rabbit anti-phospho-EphB was generated against the peptide 
CMKIY*TFPFTY*EDPNE, where Y* denotes phosphorylation, and affinity purified on 
two peptide columns. Mouse anti-β-actin (Abcam) was used as a loading control where 
appropriate. 
All Western Blots were performed with the quantitative Odyssey Infrared 
Imaging System (Licor) using fluorescently labeled secondary antibodies (Rockland 
Immunochemicals). To quantify band intensity, median fluorescence intensity within a 
two pixel border was subtracted as background. 
 
Immunoprecipitation 
For immunoprecipitations, neurons were collected and homogenized in RIPA 
buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.5% Sodium 
Deoxycholate, 0.1% SDS, 10 mM NaF, complete protease inhibitor cocktail tablet 
(Roche), 1 mM sodium orthovanadate, and Phosphatase Inhibitor cocktails 1 and 2 (1x; 
Sigma)). After clearing lysates by centrifugation for 15 minutes at 14,000 x g, 
supernatants were incubated with appropriate antibody for 1-2 hour at 4°C, followed by 
addition of Protein-A Fastflow Agarose beads (Sigma) for 1 hour. Beads were washed in 
lysis buffer or PBS three times and eluted in 2x SDS sample buffer followed by boiling. 
The following antibodies were used for immunoprecipitation experiments: rabbit 
anti-Vav2 (generated in the Greenberg lab and described previously (Cowan et al., 2005); 
mouse anti-pan-phosphotyrosine (py99) (Santa Cruz); rabbit anti-EphA4 (generated in 
the Greenberg lab against a GST-fusion of the intracellular region of EphA4).   63
 
Neuronal cell culture 
Cortical and hippocampal neurons were prepared from E15-E17 mouse embryos. 
Embryos were removed from the uterus and placed in ice-cold dissection media (10 mM 
MgCl2, 10 mM HEPES, 1 mM kynurenic acid in HBSS). Cortices or hippocampi were 
dissected, digested with papain (Worthington), rinsed three times with ovomucoid trypsin 
inhibitor (Worthington), and gently triturated. Cultured neurons were maintained in 
Neurobasal Medium (Invitrogen) supplemented with 2% B27 (Invitrogen), 
penicillin/streptomycin (100 U/mL and 100 μg/mL, respectively, Gibco), and 2 mM 
glutamine (Gibco). For biochemistry, neurons were seeded at a density of 2x10
^6 
neurons/well of a 6-well plate coated with polyornithine (Sigma). For electrophysiology 
and imaging, neurons were seeded at a density of 7.5x10
^4 neurons/well of a 24-well 
plate on a glial monolayer on glass coverslips coated with polyornithine and laminin 
(Invitrogen) or at 1.25x10
^5 neurons/well on laminin/polyornithine coverslips for imaging 
at 1 DIV. 
 
Ephrin stimulation 
For ephrin stimulations in dissociated cultured neurons and retinal explants, 
mouse ephrin-B1-FC or ephrin-B2-FC (1 μg/ul; R&D Systems) was pre-clustered for 50 
minutes with goat anti-human IgG FC (1.3 μg/μl; Jackson Immunoresearch) at room 
temperature in PBS at a molar ratio of 1:1 prior to stimulation. Pre-clustered ephrin-B1-
FC or ephrin-B2-FC was added to the appropriate medium at a final concentration of 2.5   64
μg/mL. As a control, clustered human FC in media was applied to neurons where 
specified. 
 
Surface labeling 
Labeling of surface proteins was performed using the Pierce Cell Surface Protein 
Isolation Kit (Thermo Scientific). After chronic treatment with vehicle or 1 µM 1-NA-
PP1, cultured cortical neurons were incubated with EZ-link biotin for 30 minutes at room 
temperature, washed with PBS, and lysed in RIPA buffer. Lysates were 
immunoprecipitated with antibodies to EphB2 (or control IgG), and probed with anti-
EphB2 or fluorescently labeled streptavidin (Invitrogen). 
 
Pharmacology 
1-NA-PP1 was synthesized as described previously and dissolved in DMSO 
(Wang et al., 2003). 3-MB-PP1 was synthesized using a similar procedure and dissolved 
in DMSO. Dose response curves using 1-NA-PP1 and 3-MB-PP1 were calculated on 
GraphPad Prism using the least-squares method. The vehicle dose was calculated as two 
orders of magnitude below the lowest dose (=0.05 nM). For WT EphBs, 100% inhibition 
was defined at 1 mM. 
 
EphB clustering assay 
1 DIV dissociated cortical neurons were stimulated for 1 hour with clustered 
ephrin-B1 or FC as in Takasu et al., 2002 (Takasu et al., 2002). Neurons were fixed in   65
4% PFA/2% sucrose in PBS for 8 minutes, blocked in 5% goat serum, 0.1% gelatin, 0.3% 
Triton-X 100, 0.01% sodium azide in PBS for 2 hours, stained with rabbit anti-EphB2 
(Santa Cruz; 2 μg/mL) and chicken anti-MAP2 (Abcam, 3.8 μg/mL) and mounted on 
slides using Fluoromount-G (Southern Biotech). Five confocal z-stacks of 1 μm thickness 
were acquired on a laser scanning Zeiss Pascal microscope using a 63× objective and 
maximum intensity z-projections were constructed. Metamorph image analysis software 
was used to identify the number of EphB2 clusters per area of MAP2-stained neuronal 
dendrite. 
 
Quantitative PCR 
Total RNA was isolated from mouse 7 DIV cortical cultures using Trizol reagent 
(Invitrogen) according to the manufacturer’s instructions. Isolated RNA was treated with 
DNAseI Amplification Grade (Invitrogen) and a cDNA library was synthesized by cDNA 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). The cDNA was 
the source of input for quantitative PCR, using a Step One Plus Real-Time PCR 
Instrument and SYBR Green reagents (Applied Biosystems). The relative expression plot 
was generated using concentration values that were normalized to corresponding β-actin 
concentrations. The following qPCR primer pairs were used: 
EphB1-F- ACTGCAGAGTTGGGATGGAC 
EphB1-R- CATCATAGCCACTGACTTCTTCC 
EphB2-F- TTCATGGAGAACGGATCTCTG   
EphB2-R- GACTGTGAACTGCCCATCG   
EphB3-F- CCCTGGACTCCTTTCTACGG   
EphB3-R- GCAATGCCTCGTAACATGC   66
Chapter 3 
EphB receptor tyrosine kinase signaling in axon 
guidance   67
3.1 Background 
The unique power and enormous computing capabilities of the brain derive from 
its extensive wiring. These synaptic connections are made possible by the proper 
guidance of billions of axons to their targets. Axon navigation in the nervous system is 
mediated by several families of guidance molecules using attractive and repulsive cues to 
direct the axonal growth cone. 
Early evidence suggested that EphBs plays a critical role in some of these axon 
guidance decisions (Henkemeyer et al., 1996). However, it was not clear whether this 
function was mediated by the kinase activity of EphBs or other modes of EphB signaling 
such as through PDZ-domain interactions, receptor aggregation, reverse signaling 
through ephrin-Bs, or EphB extracellular domain interactions. In general, the 
mechanisms by which axon guidance receptors signal growth cone attraction or repulsion 
have been challenging to identify. It is noteworthy that most axon guidance receptors that 
have been studied to date appear not to signal by activating protein kinases (O'Donnell et 
al., 2009). Indeed, many of the experiments studying EphBs suggest a role for kinase-
independent signaling. However, these studies faced significant technical limitations that 
make their findings inconclusive. 
 
Commissural axons of the cortex 
While EphB2 knockouts display a defective anterior commissure (AC), EphB2-
lacZ knockin mice do not share this phenotype (Henkemeyer et al., 1996). This finding 
has led investigators to conclude that reverse signaling is responsible. The kinase-  68
independent role was later supported by a study showing first, that ephrinBs are 
expressed on AC axons, and second, that ephrinB lacZ mice have an AC defect (Cowan 
et al., 2004). The authors reasoned that since the intracellular domain of ephrin-B2 was 
required for AC formation, then the role of EphBs must be as ligands and not receptors. 
However, this conclusion does not consider the fact that ephrin clustering and forward 
signaling could also be defective in the ephrin-lacZ mice. 
A more convincing experiment was performed while studying the role of the 
related EphA family of receptors in forming the anterior commissure. While EphA4 
knockouts have an AC defect, an EphA4 kinase inactive point mutation knockin has no 
effect on AC development, thus arguing for a kinase-independent role (Kullander et al., 
2001). While this experiment improves upon those using the lacZ mutants in the EphB 
field, the conclusions may not apply to the EphB family. 
Analysis of another major commissural tract, the corpus callosum (CC), has 
yielded similar results. Several mouse mutants have defective CCs, since many molecules 
orchestrate CC formation during mouse embryonic development (Donahoo and Richards, 
2009). Of interest, EphB2/EphB3 knockout mice display agenesis of the corpus callosum 
(Orioli et al., 1996). However, this defect is not seen in mice in which the intracellular 
region of EphB2 is replaced by lacZ, thus arguing for a reverse signaling mechanism 
(Mendes et al., 2006). 
This conclusion is supported by data from studies of ephrin-B mouse mutants. 
Ephrin–B1 knockout mice have a CC defect, as do ephrin-B1 knockin mutants where the 
PDZ-binding motif has been destroyed (Bush and Soriano, 2009). In addition, in vitro 
experiments suggest that ephrin-B1 is expressed on axons that form the corpus callosum,   69
while EphB2 is expressed on the midline guidance glia (Bush and Soriano, 2009). Thus, 
the available evidence points to a kinase-independent role for EphBs in commissural 
axon guidance in the cortex. 
 
Retinal axon guidance 
Much of what is currently known about the role of EphB signaling during axon 
guidance in vivo comes from studies of the guidance of retinal ganglion cell (RGC) axons 
to their targets in the lateral geniculate nucleus (LGN) and superior colliculus (SC) 
(Feldheim and O'Leary, 2010; Flanagan, 2006; Petros et al., 2008). During the course of 
visual system development, an RGC axon encounters a number of choice points as it 
travels to the optic disc, across the midline, along the optic tract to the SC or LGN, and 
finally to its target zone of innervation (Birgbauer et al., 2000; Hindges et al., 2002). 
Even the first step in the process, guidance to the optic disc, is defective in EphB2/EphB3 
knockouts. The authors in this study argue for a role for reverse signaling based on the 
finding that EphB2lacZ/EphB3 mice had more minor pathfinding defects than double 
knockouts (Birgbauer et al., 2000). 
One particularly important choice for RGC axons occurs at the midline. RGC 
axons from the ventrotemporal (VT) region of the retina express EphB1. At the same 
time, guide cells in the optic chiasm display a highly specific expression pattern for 
ephrin-B2 (Nakagawa et al., 2000; Williams et al., 2003). Studies using EphB1 and 
ephrin-B1/ephrin-B2 knockout mice revealed that the EphB1-ephrin-B2 interaction is 
responsible for the strong repulsion of EphB-expressing axons at the midline and 
subsequently leads to the development of the ipsilateral retinal projection in the LGN and   70
SC (Chenaux and Henkemeyer, 2011; Williams et al., 2003). In contrast to EphB1-
expressing axons, retinal axons that lack EphB1 pass through the chiasm and create the 
larger contralateral retinal projection. Previous studies by Carol Mason and colleagues 
show that overexpressed EphB1 is sufficient to drive retinal axons to ectopically project 
ipsilaterally, and that this function requires an intact EphB1 kinase domain (Petros et al., 
2009). In addition, a recent study in which a knockin mouse was made with the 
intracellular region of EphB1 replaced with lacZ showed a loss of the ipsilateral retinal 
projection, suggesting a requirement for forward EphB signaling in the formation of the 
ipsilateral retinal projection (Chenaux and Henkemeyer, 2011). Notably, it was not 
shown in these previous in vivo studies if the axon guidance function of endogenous 
EphBs requires tyrosine kinase signaling. 
In addition to the optic chiasm, forward signaling of EphBs has been implicated in 
the guidance of spinal commissural axons (Kadison et al., 2006). This conclusion was 
based on the presence of guidance errors in ephrin-B3 knockout mice, but not in ephrin-
B3 lacZ mice. 
 The conclusion from these studies is that a mix of forward and reverse signaling 
determines various axon decisions mediated by EphBs. However, these techniques are all 
indirect and are therefore not conclusive. For example, the EphB2 lacZ fusion protein can 
be phosphorylated at juxtamembrane residues and may be able to engage in some modes 
of signaling, or might inhibit others (Grunwald et al., 2001). We sought to directly test 
these questions using the As-EphB TKI mice. 
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3.2 EphB tyrosine kinase activity in growth cone collapse 
To determine if the kinase activity of EphBs is required for growth cone collapse 
and axon guidance, we began by examining the effect of inhibiting the kinase activity of 
EphBs on ephrin-B2-dependent growth cone collapse in actively growing retinal ganglion 
cell (RGC) axons. We prepared explants from embryonic day 14 (E14) ventrotemporal 
retinae, a time and region where EphBs are highly expressed (Williams et al., 2004). 
Growth cones were visualized with fluorescent phalloidin (to label F-actin) and axons 
were identified by staining with anti-neurofilament antibodies (Figure 3.1A). In these 
explants RGCs extend axons with broad, fan-shaped growth cones over a laminin 
substrate. We measured the state of growth cones by two methods: first, growth cones 
were scored as collapsed if they exhibited rod-like morphology and lacked visible 
lamellipodia. This method allowed us to quantify the percentage of growth cones that 
were collapsed in each explant. Second, we measured the maximum axial width of each 
growth cone and calculated the average axial width of the growth cones in each explant. 
To test whether treatment of explants with 1-NA-PP1 and 3-MB-PP1 led to 
inhibition of ephrinB-dependent EphB tyrosine phosphorylation, we stained explants with 
an antibody to phosphorylated EphBs. In the absence of stimulation, no phospho-EphB 
staining was observed in growth cones from WT or AS-EphB TKI explants (Figure 
3.1A). Upon ephrin-B2 stimulation, punctate patterns of anti-phospho-EphB antibody 
staining were seen in the growth cone and along the axon (Figure 3.1A). This staining 
was blocked in 1-NA-PP1 (250 nM) or 3-MB-PP1 (1 μM)-treated AS-EphB TKI explants, 
but not in WT explants, indicating that PP1 analogs selectively inhibit the kinase activity 
of EphBs in AS-EphB TKI RGC explants (Figure 3.1A).   72
 
Figure 3.1: EphB-dependent growth cone collapse in retinal explants 
(A) Embryonic day 14 (E14) VT retinal explants were preincubated for 1 hour with 
vehicle, 250 nM 1-NA-PP1, or 1 μM 3-MB-PP1 before a 30 minute ephrin-B2 
stimulation. Explants were fixed and stained with neurofilament (red), phospho-EphB 
(blue) and labeled with phalloidin (green). 
White arrows denote clusters of phospho-EphB staining. Scale bar represents 10 μm.   73
 
Figure 3.1 (continued) 
(B) Quantification of the percentage of collapsed growth cones per explant from (A). A 
2-way ANOVA revealed a significant interaction between genotype and inhibitor 
treatment in each of the conditions, indicating that PP1 analog treatment effects were 
significantly greater in AS-EphB TKI neurons than in WT neurons: 
% collapsed growth cones, vehicle vs. 1-NA-PP1: F(1,20)=6.66, p=.018 
% collapsed growth cones, vehicle vs. 3-MB-PP1: F(1,22)=7.41, p=.012 
Data are mean ± SEM. N=4-8 explants per condition. 
(C) Quantification of the average growth cone width per explant from (A). A 2-way 
ANOVA revealed a significant interaction between genotype and inhibitor treatment in 
each of the conditions: 
Average growth cone width, vehicle vs. 1-NA-PP1: F(1,20)=11.75, p=.0027 
Average growth cone width, vehicle vs. 3-MB-PP1: F(1,22)=11.49, p=.0026 
Data are mean ± SEM. N=4-8 explants per condition.   74
When treated with clustered ephrin-B2, VT growth cones from AS-EphB TKI 
explants collapse robustly (from 4 ± 2% of growth cones collapsed in the unstimulated 
condition to 60 ± 7% collapsed in the stimulated condition) (Figure 3.1A, B). Treatment 
of AS-EphB TKI explants with 1-NA-PP1 (250 nM) or 3-MB-PP1 (1 μM) led to a 
dramatic decrease in the percentage of collapsed growth cones upon ephrin-B treatment 
(10 ± 4% and 6 ± 2% of growth cones, respectively) (Figure 3.1A, B). In addition, AS-
EphB TKI explants showed an ephrin-B2-induced decrease in growth cone width from 
10.4 ± 0.5 μm to 4.6 ± 0.6 μm in vehicle-treated explants, but only a slight reduction to 
8.4 ± 0.5 μm and 9.5 ± 0.4 μm in explants exposed to 1-NA-PP1 or 3-MB-PP1, 
respectively (Figure 3.1A, C).  
As an important control, this drug-dependent blockade of growth cone collapse 
was not seen in WT explants: WT cells showed a robust collapse regardless of the 
presence of inhibitors (56 ± 7% of growth cones collapsed in 1-NA-PP1 and 51 ± 7% in 
3-MB-PP1 compared to 65 ± 11% in the absence of drug) as well as a significant 
reduction in average growth cone width after stimulation (4.1 ± 0.3 μm and 5.4 ± 0.2 μm, 
respectively, compared to an average width of 10.2 ± 0.7 μm in explants not exposed to 
ephrin-B2) (Figure 3.1A, B). 
To rule out the possibility that inhibiting EphBs leads to general changes in cell 
health within the retinal explants, we washed out 1-NA-PP1 (250 nM) midway through a 
30 minute ephrin-B2 stimulation in AS-EphB TKI explants. Whereas in the presence of 
1-NA-PP1, ephrin-B-stimulated growth cones were uncollapsed (3 ± 2% of growth 
cones), after washout growth cones rapidly collapsed (54 ± 10% of growth cones were 
collapsed) (Figure 3.2A, B). This finding demonstrates the reversibility of PP1 analog   75
inhibition of the kinase activity of EphBs in retinal explants and rules out cell death as a 
cause of reduced growth cone collapse. We conclude that the kinase activity of EphBs is 
required for ephrin-B-induced growth cone collapse. 
 
 
Figure 3.2: Reversible blockade of growth cone collapse in AS-EphB TKI explants 
(A) E14 VT retinal explants were treated with 1-NA-PP1 (250 nM) as in Figure 3.1, but 
15 minutes into a 30 minute ephrin-B2 stimulation, media was removed and replaced 
with vehicle. Scale bar represents 10 μm. 
(B) Quantification of the percentage of collapsed growth cones per explant from (A). 
Data are mean ± SEM. N=4 explants per condition.  76
3.3 The kinase activity of EphBs is required for axon guidance at the 
optic chiasm 
Axon guidance in vivo is considerably more complex than the in vitro process of 
growth cone collapse. For example, the saltatory motion of growth cones in vivo involves 
more than simple extension and collapse, and often includes intermediate movements 
(Mason and Wang, 1997). To determine whether the kinase activity of EphBs is required 
for the repulsive guidance of axons in vivo, we examined the effect of inhibiting the 
kinase activity of EphBs on axon repulsion at the optic chiasm. 
 
In vivo EphB tyrosine kinase inhibition 
  In determining how to treat AS-EphB TKI mice in vivo, we considered several 
approaches. An earlier study with AS-Trk mutants used oral administration and booster 
intraperitoneal (IP) injections (Chen et al., 2005). While oral administration is convenient, 
the effective concentration may not be high enough and it would require large amounts of 
inhibitor that need to be synthesized. IP injections provide a high effective dose, but they 
are cleared rapidly and might require frequent injections to see a phenotype. Based on 
unpublished data from Zach Knight and Chao Zhang of the Shokat lab, we decided to try 
subcutaneous injections since the clearance rate is substantially slower than for IP 
injections. 
  Determining the effective dose of inhibitor in the nervous system is challenging. 
A radiolabeling assay measuring tritium-labeled 1-NM-PP1, another PP1 analog, in the 
brain suggests that PP1 analogs cross the blood brain barrier (Wang et al., 2003).   77
However, this study showed that 1-NM-PP1 levels in the brain after IP injections only 
lasted for one hour. Also, there is the caveat that these studies using brain homogenates 
from mice may contain contaminating tissue such as blood vessels. 
  For our assays, we used twice daily injections of 80mg/kg 1-NA-PP1 dissolved in 
10% DMSO, 20% Cremaphor-EL, 70% Saline. 
 
Formation of the ipsilateral retinal projection 
To test whether the tyrosine kinase activity of EphBs is required for formation of 
the ipsilateral retinal projection, we treated pregnant female mice with 1-NA-PP1 from 
E13.5-16.5, the time when RGC axons encounter the optic chiasm. By E16, much of the 
ipsilateral projection has already formed. To label the retinal projections at E16, we fixed 
embryos and applied DiI crystals to the optic disc to allow selective anterograde labeling 
of the retinal projections from one eye (Figure 3.3A). 
To assess the degree of ipsilateral vs. contralateral retinal projection, we measured 
the fluorescence intensity of a rectangular region in the ipsilateral projection and divided 
this by the total fluorescence intensity in the combined ipsilateral and contralateral 
projections to derive the Ipsilateral Index (Williams et al., 2003). In 1-NA-PP1-treated 
AS-EphB TKI embryos, we found that the ipsilateral retinal projection was strongly 
reduced (by 42%) compared to untreated AS-EphB TKI embryos (Figure 3.3B, C). In 
many of the AS-EphB TKI embryos treated with 1-NA-PP1, the ipsilateral projection 
was completely absent. By contrast, 1-NA-PP1 treatment had no effect on the ipsilateral   78
retinal projection in WT embryos, indicating that the observed guidance deficit was due 
to specific inhibition of EphBs (Figure 3.3B, C). 
 
 
 
Figure 3.3: The formation of the ipsilateral retinal projection requires EphB 
tyrosine kinase signaling 
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Figure 3.3 (continued) 
(A) Representative image demonstrating the orientation of the ipsilateral and contralateral 
retinal projections of the optic tract with respect to the optic chiasm as visualized by DiI 
labeling. Scale bar represents 100 μm. 
 
(B) Twice-daily subcutaneous injections of 80 mg/kg 1-NA-PP1 were administered to 
pregnant mice from E13.5-E16.5. Graph depicts quantification of the Ipsilateral Index 
normalized for each genotype. The number of embryos examined was as follows: 
Untreated AS-EphB TKI (n=30), 1-NA-PP1-treated AS-EphB TKI (n=30), Untreated 
WT (n=15), 1-NA-PP1-treated WT (n=17). 
***, p<.001; n.s., not significant by Student’s t-test. A 2-way ANOVA revealed a 
significant interaction between genotype and inhibitor treatment, indicating that 1-NA-
PP1 treatment effects were significantly greater in AS-EphB TKI embryos than in WT 
embryos (F(1,88)=6.5, p=.0125). Data are mean ± SEM. 
 
(C) Representative images of DiI-filled retinal projections at E16.5. C57BL/6 WT mice 
in untreated condition show a larger ipsilateral component than untreated AS-EphB TKI 
mice, but display no response to 1-NA-PP1 treatment. 
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We conclude a requirement for the tyrosine kinase activity of EphBs in mediating 
the guidance decision at the optic chiasm. It is worth noting that this phenotype is often 
strain-specific and exact background matches cannot be obtained for the AS-EphB TKI 
mice. The baseline level of ipsilateral projection size for the highly inbred, mixed-strain 
AS-EphB TKI mice was lower than for WT mice (Figure 3.3C). Thus, the formal 
possibility remains that the AS-EphB TKI mice are hypomorphic in this regard. However, 
no other assays revealed any evidence of hypomorphism. 
 
3.4 EphB tyrosine kinase signaling regulates the formation of cortical 
tracts 
  Based on the finding that EphB tyrosine kinase activity mediates axon guidance at 
the optic chiasm, we next asked about its role in other commissural axon tracts in the 
brain. EphB knockout mice have defects in the corpus callosum and anterior commissure 
that are thought to be kinase-independent, although it has not been possible to test this 
directly. We treated pregnant mice with 1-NA-PP1 from E12.5-19.0, harvested embryos, 
then fixed and stained the brains with an antibody to L1-CAM to visualize major axon 
tracts. Based on studies of the EphB knockouts, there are three major tracts of interest: 
the corpus callosum, the anterior commissure, and the corticofugal tracts. 
Untreated AS-EphB TKI mice had normal corpus callossa (0/6 agenesis) (Table 
3.1) (Figure 3.4). However, AS-EphB TKI mice treated with 1-NA-PP1 all had partial 
corpus callosum agenesis with a gap in the dorsal midline region (11/11) (Table 3.1) 
(Figure 3.4). While fully penetrant, the phenotype is not as severe as in the EphB TKO, 
which may be explained by incomplete pharmacological inhibition. WT mice treated with   81
1-NA-PP1 had a normal corpus callosum (0/6), demonstrating that this phenotype was 
specific to inhibition of EphBs (Table 3.1) (Figure 3.4). These data suggest that the 
tyrosine kinase activity of EphBs is required for proper formation of the corpus callosum, 
in contrast to earlier studies (Mendes et al., 2006). 
 
 
 
 
CONDITION N 
CORPUS 
CALLOSUM    
(PARTIAL 
AGENESIS) 
ANTERIOR 
COMMISURE    
MISPROJECTION 
(+) 
ANTERIOR 
COMMISURE 
MISPROJECTION 
(+++) 
CORTICOFUGAL 
MISPROJECTION
AS-EphB TKI 
untreated  6  0% (0)  0% (0)  0% (0)  0% (0) 
AS-EphB TKI 
+ 1-NA-PP1  11  100% (11)  0% (0)  100% (11)  64% (7) 
WT untreated  6  0% (0)  16% (1)  0% (0)  0% (0) 
WT           
+ 1-NA-PP1  6  0% (0)  50% (3)  0% (0)  0% (0) 
 
Table 3.1: Summary of cortical phenotypes in AS-EphB TKI and WT mice. 
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Figure 3.4: EphB tyrosine kinase activity is required for formation of the corpus 
callosum 
Twice-daily subcutaneous injections of 80 mg/kg 1-NA-PP1 were administered to 
pregnant mice from E12.5-E19.0. Brain sections from E19.0 embryos were stained with 
L1-CAM antibody to visualize axon tracts. Red arrows denote the corpus callosum. 
Further details are described in Table 3.1. 
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After noting this highly penetrant corpus callosum defect, we next examined the 
anterior commissure. Untreated AS-EphB TKI mice had normal anterior commissures 
(0/6 misprojected) (Table 3.1) (Figure 3.5). However, mice treated with 1-NA-PP1 all 
had partially misprojected anterior commissure tracts (11/11) (Table 3.1) (Figure 3.5). In 
these mice, the posterior branch of the anterior commissure (ACp) contained large 
branches that failed to join the primary ACp white matter tract toward the ventral midline. 
Untreated WT mice were generally normal (0/6), but displayed some minor 
misprojections of the AC with a few misguided fibers (1/6) (Table 3.1) (Figure 3.5). WT 
mice treated with 1-NA-PP1 also displayed similarly minor misprojections (3/6), but did 
not have any significantly misguided ACs (0/6) (Table 3.1) (Figure 3.5). The small 
number of partially misguided ACs in WT may demonstrate a partial off-target effect, but 
this phenotype is still much less severe than that seen in the AS-EphB TKI mice. Thus, 
we can conclude that the tyrosine kinase activity of EphBs is required for proper 
formation of the anterior commissure, in contrast to previous studies (Cowan et al., 2004; 
Henkemeyer et al., 1996). 
To better quantify this finding, we measured thickness of the posterior branch of 
the anterior commissure in sections where ACp fiber bundles visibly crossed the midline. 
While untreated AS-EphB TKI mice had ACp widths of 162 ± 11 μm, 1-NA-PP1 treated 
mice had significantly thinner tracts of 94 ± 5 μm (Figure 3.5B). WT mice did not 
display a significant reduction (from 159 ± 10 μm to 138 ± 7 μm) (Figure 3.5B).   84
 
Figure 3.5: The proper formation of the anterior commissure requires EphB 
tyrosine kinase function 
(A) Twice-daily subcutaneous injections of 80 mg/kg 1-NA-PP1 were administered to 
pregnant mice from E12.5-E19.0. Brain sections from E19.0 embryos were stained with 
L1-CAM antibody to visualize axon tracts. Yellow arrows denote the posterior branch of 
the anterior commissure. 
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Figure 3.5 (continued) 
(B) Quantification of tract width from (A). 
***, p<.001; n.s., not significant by Student’s t-test. A 2-way ANOVA revealed a 
significant interaction between genotype and inhibitor treatment, indicating that 1-NA-
PP1 treatment effects were significantly greater in AS-EphB TKI embryos than in WT 
embryos (F(1,25)=8.7, p=.007). Data are mean ± SEM. Further details are described in 
Table 3.1. 
 
 
 
 
Recent unpublished experiments from Michael Robichaux in the laboratory of 
Chris Cowan at the University of Texas Southwestern have identified corticofugal (CF) 
tract defects in EphB KO mice. We examined these tracts in AS-EphB TKI mice. 
Untreated mice were normal (0/6), but 1-NA-PP1 treated mice had pronounced defects in 
the corticofugal tract (7/11) (Table 3.1). CF axon bundles often failed to integrate into 
the internal capsule and instead grew aberrantly through the ventral striatum. Untreated 
WT mice displayed normal CFs (0/6) as did 1-NA-PP1-treated WT mice (0/6) (Table 
3.1). We conclude that the tyrosine kinase activity of EphBs is required for proper 
formation of corticofugal tracts. 
 
3.5 Discussion 
Kinase-dependence of axon guidance 
Taken together, these data demonstrate for the first time a requirement for the 
kinase activity of EphBs in axon guidance in vivo. In fact, all four of the axon tracts we   86
examined required EphB tyrosine kinase signaling. These experiments highlight the 
ability of the chemical-genetic approach to inhibit the kinase signaling of EphBs at 
defined times in vivo during embryonic development and should make it possible to 
examine the importance of the kinase activity of EphBs in other axon guidance decisions. 
Our data disagree with previously reported findings using lacZ fusion proteins 
(Henkemeyer et al., 1996; Mendes et al., 2006). As discussed previously, these fusion 
proteins may lead to functional compensation or may still engage in unexpected modes of 
signaling. Our results suggest that a second look at assays using ephrin-B/EphB lacZ 
fusion proteins would be critical. In addition, previous studies that blocked ephrin-B 
reverse signaling may have perturbed EphB tyrosine kinase activity as well, thus leading 
to defects in axon guidance. 
 
Mechanism of EphB-mediated axon repulsion 
Signaling pathways at the growth cone often converge on regulators of the actin 
cytoskeleton. However, very little is known about the mechanism of EphB-kinase-
dependent growth cone collapse. In fact, little is known about the mechanism of growth 
cone collapse in most major guidance systems. Studies of the related EphA family of 
RTKs suggest a possible role for the Ephexin and Vav Rho family GEFs in this process 
(Cowan et al., 2005; Sahin et al., 2005; Shamah et al., 2001). While Rho family GTPases 
are good candidates to bridge RTKs to the actin cytoskeleton, we find that RhoA 
inhibitors do not affect EphB-dependent growth cone collapse in retinal explants. 
Consistent with this finding, growth cone collapse still occurs in explants from Ephexin5 
knockout mice (M.J.S., unpublished). Recent studies show that a key component of the   87
RhoA pathway, Rho associated protein kinase (ROCK), is also not required for ephrin-B-
induced growth cone collapse, although it is required for axon retraction (Petros et al., 
2010). 
As our data suggest that the tyrosine kinase activity of EphBs is required for 
growth cone collapse, the identification of substrates of EphBs in the growth cone that 
are not involved in RhoA signaling may help to elucidate further the mechanism of 
EphB-dependent growth cone collapse. With the development of orthologous ATP-
analogues that are selectively used by AS kinases, it is possible to directly label 
substrates of an AS kinase (Banko et al., 2011). Thus, the AS-EphB mice may facilitate 
the identification of EphB substrates that help mediate the effects of ephrin-B/EphB 
signaling on axon guidance. 
  Based on the available data, we propose a model where Vav2/3 may act 
downstream of EphBs in mediating guidance at the optic chiasm. We have demonstrated 
that Vav2 is phosphorylated downstream of EphBs, and it will be important to test this in 
retinal explants. A previous study investigating Vav2/Vav3 knockout mice demonstrated 
defects in the ipsilateral retinal projection to the LGN (Cowan et al., 2005). This process 
was thought to be dependent on Rac1, which may mediate endocytosis in the growth 
cone (Jurney et al., 2002). As effectors of EphB-mediated axon guidance in cortical tracts 
are yet to be identified, it will be worthwhile to investigate whether the signaling 
processes there are similar to those in the retina. 
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3.6 Materials and methods 
Retinal explants 
Ventrotemporal (VT) segments of retina were microdissected from E14.5 mouse 
embryos and cultured as previously described (Petros et al., 2010). Embryos were 
removed from the uterus and decapitated, and heads were placed in ice-cold DMEM/F12 
(Gibco). VT sections of the retina were excised and placed on glass coverslips coated 
with polyornithine and laminin. Explants were maintained in serum free medium (10 
mg/mL BSA (Sigma), 1% ITS supplement (Sigma), Pen/Strep (20 U/mL and 20 μg/mL, 
respectively, Gibco) in DMEM/F12) supplemented with 0.2% methyl cellulose (Sigma) 
to increase media viscosity and minimize explant movement. All experiments were 
conducted 18-24 hour after initial plating. 
 
Immunocytochemistry and growth cone collapse assay 
For experiments with drug treatment, explants were pretreated with vehicle or 
PP1 derivatives for 1 hour, followed by a 30 minute ephrin-B2 stimulation, with 
variations as described in the text. Following stimulation, retinal explants were fixed for 
20 minutes at 25°C with 4% paraformaldehyde/2% sucrose in PBS. Explants were then 
blocked in 10% Goat Serum, 0.2% Tween-20 in PBS for 1 hour, followed by incubation 
with neurofilament antibody or phospho-EphB antibody in 50% blocking solution 
overnight. Mouse anti-neurofilament, (2H3) originally derived in the laboratory of 
Thomas Jessell, was obtained from the Developmental Studies Hybridoma Bank. Rabbit   89
anti-phospho-EphB was generated against the peptide CMKIY*TFPFTY*EDPNE, where 
Y* denotes phosphorylation, and affinity purified on phospho-Eph peptide columns. 
After PBS washes, explants were incubated in Alexa Fluor-conjugated secondary 
antibodies (Invitrogen) and Alexa Fluor 488-conjugated phalloidin (Invitrogen). Explants 
on coverslips were mounted on glass slides using Fluoromount-G (Southern Biotech). 
Neurons were imaged using a laser scanning Zeiss Pascal microscope using a 40× 
objective with sequential acquisition settings at 1024 × 1024 pixel resolution. All 
imaging and image analysis were performed blind to the genotype and treatment 
condition of the samples. At least 10 growth cones were analyzed per explant. 
 
In Vivo 1-NA-PP1 delivery 
Pregnant female WT or AS-EphB TKI mice were injected subcutaneously twice 
daily with 80mg/kg 1-NA-PP1 dissolved in 10%DMSO, 20% Cremaphor-EL, 70% saline 
from E13.5 to E16.5 for optic tract experiments or from E12.5-E19.0 for cortical tract 
experiments. 
 
DiI labeling of the optic tract 
DiI labeling was performed as previously described by Plump et al. (Plump et al., 
2002). E16.5 embryo heads were fixed in 4%PFA /2% sucrose in PBS overnight and then 
washed with PBS. The lens and retina were removed from the left eye and a small crystal 
of DiI (Invitrogen) was placed in the optic disc. The retina was then replaced securely 
and the heads were stored in PBS+0.1% azide at room temperature for 12 days. After   90
labeling, brains were removed and fluorescent optic tracts were imaged on a Leica 
MZ16F fluorescent stereomicroscope. Images were captured using Spot Advanced 
software. Labeling was quantified using Metamorph software by drawing rectangular 
regions of interest around the ipsilateral and contralateral tracts, subtracting background, 
and calculating the ipsilateral index based on integrated intensity of fluorescence: 
ipsilateral index = ipsilateral / (ipsilateral + contralateral). 
To compare WT and AS-EphB TKI responses with respect to 1-NA-PP1 treatment, each 
genotype was normalized to its untreated condition, producing a normalized ipsilateral 
index. 
 
Labeling of cortical tracts 
E19.0 embryos were decapitated and fixed in 4% PFA/2% sucrose in PBS for 2 
days, then stored in PBS + .02% sodium azide at 4°C. Brains were removed and 
vibratome sectioned to 70 µm. Sections were blocked in 5% normal donkey serum, 1% 
BSA, 0.2% glycine, 0.2% lysine with 0.3% TritonX-100 in PBS at room temperature for 
1 hour. To stain axon tracts, sections were incubated with rat anti-L1-CAM (Millipore, 
MAB5272MI) 1:200 in blocking solution at 4°C overnight. Sections were washed three 
times with PBS and incubated with Cy3-conjugated donkey anti-rat IgG (Jackson) for 1.5 
hours. Sections were washed 7-8 times with PBS and mounted with Aqua-mount (Lerner 
laboratories). Sections were imaged on an Olympus Bx51 epifluorescent microscope at 
4x magnification. 
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Scoring of cortical phenotypes 
All in vivo experiments included data from at least two separate litters of embryos 
per condition. Corpus callosum (CC) partial agenesis was scored as the apparent failure 
of CC axons to cross the midline in a specific region along the rostral-caudal brain axis, 
and was evident by a gap in the dorsal midline region. 
Misprojections of the posterior branch of the anterior commissure (ACp) were 
scored by the observation of ACp axon fibers that failed to join the primary ACp white 
matter tract toward the ventral midline. These misprojections often occured as the 
primary ACp tract turns medially toward the midline. The severity of the ACp 
misprojections was scored based on the apparent number of misguided axons. Large 
bundles of misprojected axons are represented as (+++), while a few misguided fibers are 
represented as (+). 
For ACp measurements, images were acquired under 10x magnification and 
sections were chosen where the ACp fiber bundle visibly crossed the midline. 
Measurements were made using the ImageJ line tool to quantify the width of the AC fiber 
path in the caudate putamen region (to isolate the posterior component). 
  Corticofugal (CF) misprojections were scored by the observation of CF axon 
bundles that failed to integrate into the internal capsule and instead grew aberrantly 
through the ventral striatum toward the brain floor. 
 
Statistical analysis: 
T-tests and 2-way ANOVA analyses were conducted using GraphPad Prism software. All 
error bars represent SEM.   92
Chapter 4 
EphB receptor tyrosine kinase signaling in 
synapse development 
   93
4.1 Background 
Molecular mechanisms of synaptogenesis 
EphBs were one of the first members of a growing class of molecules implicated in 
the formation of excitatory synapses (Waites et al., 2005). Most excitatory synapses in 
the brain form onto dendritic spines, small bulb-like structures that can compartmentalize 
signaling (Yuste and Denk, 1995). The development of synapses and the development of 
spines are intimately related, although still quite separate phenomena (Yuste and 
Bonhoeffer, 2004). EphBs have been repeatedly implicated in spine development as well 
as synaptogenesis. 
There have been conflicting reports as to the timing of pre- vs. postsynaptic phases 
of synaptogenesis, but it appears that these confusions reflect a heterogeneity of synapses 
in terms of developmental patterns (McAllister, 2007). Similarly, spine development 
depends on sex, species, and brain region (Zhang and Benson, 2000). Thus, descriptions 
of spine and synapse formation must be considered in their appropriate developmental 
contexts. Still, excitatory synapse formation in the CNS follows several general trends. 
After the guidance of an axon to its proper target field, nascent synapses begin to 
form on dendritic shafts and filopodia, thin, highly motile structures (Ziv and Smith, 
1996). Interactions between pre- and postsynaptic structures are mediated by cell 
adhesion molecules that allow a reciprocal induction of the presynaptic terminal and the 
postsynaptic density (Waites et al., 2005). These adhesive interactions involve several 
families of molecules and are thought to underlie a large part of the specificity of 
synaptic connections. It is at this point that EphBs are thought to act since they can signal 
bidirectionally at the synapse (Kayser et al., 2008). However, studies of neuroligin have   94
shown that synapse maturation and stabilization can be equally important for determining 
synapse specificity (Chubykin et al., 2007). 
There are several opposing models of how synaptogenesis and spinogenesis relate 
in pyramidal neurons. In one model, filopodia actively seek out axonal partners, 
stabilizing along preferred sites of the axon, perhaps where glutamate is released 
(McAllister, 2007). The filopodia recruit synapses to the shaft, where spines then develop. 
This is consistent with the finding that only after the first two weeks postnatally does 
shaft synapse number start to decrease appreciably until the vast majority are spine 
synapses (Fiala et al., 1998). 
Another model proposes that synapses initially form onto filopodia, which directly 
morph into spines. Indeed, published observations of this phenomenon support the theory 
(Parnass et al., 2000). The notion that filopodia develop directly into spines is countered 
by the observation that aspiny neurons have filopodia during development, yet never 
develop spines (Portera-Cailliau et al., 2003). However, the filopodia on these aspiny 
neurons may lead to new dendritic branches, so they may be fundamentally different 
from some filopodia observed on spiny neurons. 
A final model suggests that filopodia and spines of various morphologies are in a 
constant state of flux. Filopodia are merely highly motile, very narrow spines and should 
be considered nascent spines (Nimchinsky et al., 2002). 
The underlying molecular mechanisms of spinogenesis have been investigated in 
great detail. The development of the mature spine involves Rho GTPases and 
rearrangements of the actin cytoskeleton. Generally, Rac activation promotes spine 
formation and RhoA activation prevents spine formation (Tashiro et al., 2000).   95
After formation of nascent synapses, maturation begins to occur. During this step, 
receptor subunit compositions are often altered, significant changes in neurotransmitter 
release take place, and the density of synaptic proteins is dramatically increased (Sanes 
and Lichtman, 2001). Some synapses, however, are permanently destabilized and 
eliminated. Several signaling pathways have been implicated in this maturation phase, 
including EphBs (Penzes et al., 2003). Even for the spines that remain, there is a great 
deal of dynamism. Further experiments that measure the movement of spines in genetic 
mutants are important for shedding light on the mechanism of these dynamic events. In 
the case of EphBs, recent studies suggest that dendritic filopodia from EphB TKO mice 
have decreased motility (Kayser et al., 2008).  
 
EphBs in synapse and spine development 
As discussed in Chapter 1, the evidence for EphB involvement in synapse and 
spine development is based on four independent approaches: soluble ephrin stimulation, 
overexpression of dominant negatives, RNAi, and transgenic mice. 
  Gain-of-function experiments, such as adding clustered soluble ephrin, can 
suggest the sufficiency of EphBs in certain processes, but cannot be used to test a 
requirement for EphB tyrosine kinase signaling in synaptogenesis. 
Dominant negative EphB2 overexpression leads to decreases in synapse and spine 
number (Ethell et al., 2001). While the authors of this study conclude a kinase-dependent 
role for EphBs, the use of dominant negatives is hard to interpret because the mechanism 
of perturbation is not fully understood. In addition, this approach cannot test the 
requirement of EphB tyrosine kinase activity in endogenous proteins.   96
An alternative approach that solves this problem is the use of RNAi. Kayser et al. 
have demonstrated that knockdown of EphB2 alone is sufficient to cause decreases in 
synapse density, spine density, and filopodial motility in cultured cortical neurons 
(Kayser et al., 2008). This is true even when RNAi treatments lead to only a 50% 
reduction in EphB2 staining (Kayser et al., 2008). Considering that multiple EphBs need 
to be genetically excised to see defects in hippocampal synaptogenesis and spine 
development, this result is surprising (Henkemeyer et al., 2003). Kayser et al. went on to 
show that re-expression of an EphB2 kinase inactive mutant failed to rescue synapse 
density, thus suggesting a requirement for EphB tyrosine kinase activity in 
synaptogenesis. However, this technique also relies upon overexpressed protein which 
may not be relevant to endogenous signaling. 
Transgenic mice have also been used to address the kinase dependence of EphBs. 
The EphB2 lacZ mouse (in EphB1/EphB3 KO background) has a dendritic spine 
phenotype intermediate between WT and knockout mice (Henkemeyer et al., 2003). 
Given the full penetrance of the knockin procedure, this observation is difficult to 
interpret. Even still, these experiments do not directly address the role of kinase signaling. 
Thus, none of these former studies has directly tested the requirement of the 
kinase activity of EphBs in the regulation of synapse number or function under 
conditions where ephrin-Bs and EphBs are expressed at physiological levels. This leaves 
open the possibility that aspects of EphB-dependent synapse development may be kinase-
independent. 
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4.2 EphB tyrosine kinase signaling is dispensable for synapse and spine 
formation 
EphB tyrosine kinase signaling in synaptogenesis 
To test whether synaptogenesis requires the kinase activity of EphBs or whether it 
might be mediated by a kinase-independent function of EphBs, we measured miniature 
excitatory postsynaptic currents (mEPSCs) in dissociated cortical neurons from AS-EphB 
TKI mice in the presence or absence of 1-NA-PP1. In previous studies, mEPSC 
frequency was significantly reduced in dissociated cortical neurons in which EphB2 
expression is knocked down with RNAi; this is thought to signify a reduction in the 
number of excitatory synapses (Kayser et al., 2006). We treated cultures with 1 μM 1-
NA-PP1 beginning at 3 days in vitro (DIV) until 10-12 DIV and performed whole cell 
electrophysiological recordings. Surprisingly, we found no difference in mEPSC 
frequency between AS-EphB TKI neurons treated with vehicle or 1-NA-PP1 (1.1 ± 0.3 
Hz in vehicle-treated vs. 1.1 ± 0.3 Hz in 1-NA-PP1-treated) (Figure 4.1A, B). There was 
also no significant difference in mEPSC amplitude (16.4 ± 2.5 pA in vehicle-treated vs. 
15.6 ± 1.3 Hz in 1-NA-PP1-treated) (Figure 4.1A, B). To confirm that 1-NA-PP1 inhibits 
EphB tyrosine phosphorylation in these cultures, we performed a western blot on 
concurrent cultures which showed clear inhibition of all ephrin-B-induced EphB 
autophosphorylation in the presence of 1 μM 1-NA-PP1 (Figure 4.1C).   98
 
Figure 4.1: EphB tyrosine kinase activity is dispensable for the formation of 
functional excitatory synapses in vitro 
(A) Representative traces from recordings from dissociated cortical neurons from AS-
EphB TKI embryos at 10-12 days in vitro (DIV). Cultures were treated with vehicle 
(DMSO) or 1-NA-PP1 (1 μM) from 3 DIV until the time of recording. 
(B) Quantification of frequency and amplitude of miniature excitatory postsynaptic 
currents (mEPSCs) from vehicle and 1-NA-PP1 treated neurons. Data are mean ± SEM. 
N=13 cells per condition.   99
Figure 4.1 (continued) 
 (C) Concurrent cultures treated with identical drug conditions were stimulated for 30 
minutes with ephrin-B1 at the time of recording (10 DIV) and subsequently lysed and 
processed for western blotting with antibodies to phospho-EphB and β-actin. 
 
 
Our finding that inhibition of EphB tyrosine kinase activity does not affect 
mEPSC frequency in cultures, taken together with many previous studies that have 
implicated EphBs in excitatory synapse formation (Dalva et al., 2000; Henkemeyer et al., 
2003; Kayser et al., 2008), suggests the possibility that kinase-independent EphB 
signaling mediates early synaptogenesis. To test the requirement of EphB tyrosine kinase 
signaling for synapse development using an independent method, we treated cultured 
hippocampal neurons with vehicle or 1-NA-PP1 (250 nM-5 μM) from 10-14 DIV, the 
peak of synaptogenesis. To quantify the number of excitatory synapses, we stained 
cultures with antibodies against synapsin and PSD-95, markers for pre- and post-synaptic 
specializations, respectively, and counted their overlap. Consistent with our 
electrophysiological results, we found that inhibiting EphB tyrosine kinase activity at a 
range of doses had no effect on the number of excitatory synapses as measured by the 
apposition of pre- and post-synaptic specializations (Figure 4.2). Taken together, we 
conclude that the tyrosine kinase activity of EphBs is not required for excitatory synapse 
formation and that EphBs may signal through a kinase-independent mechanism to 
regulate synaptic development.   100
 
Figure 4.2: The assembly of synapses does not require EphB tyrosine kinase activity 
Quantification of synaptic puncta density in dissociated hippocampal neuronal cultures 
sparsely transfected with GFP and treated with vehicle (DMSO) or 1-NA-PP1 (250 nM - 
5 μM) from 10-14 DIV. Neurons were fixed and stained at 14 DIV and excitatory 
synaptic puncta were defined as discrete regions of overlap between PSD-95, synapsin, 
and GFP. Data are mean ± SEM. N (neurons) = WT Vehicle (112), WT 250 nM 1-NA-
PP1 (31), WT 1 μM 1-NA-PP1 (67), WT 5 μM 1-NA-PP1 (49), AS-EphB TKI Vehicle 
(114), AS-EphB TKI 250 nM 1-NA-PP1 (31), AS-EphB TKI 1 μM 1-NA-PP1 (66), AS-
EphB TKI 5 μM 1-NA-PP1 (49).  101
EphB tyrosine kinase signaling in spinogenesis 
  Even more dramatic than the loss of synapses in EphB triple knockouts is the 
dysfunction in dendritic spine development (Henkemeyer et al., 2003). We reasoned that 
EphB tyrosine kinase signaling might regulate this morphological aspect of neural 
development, which reaches its peak between 10-21 DIV in dissociated neuronal cultures. 
Several groups have reported significant defects in spinogenesis after perturbing EphB 
function during this period (Ethell et al., 2001; Kayser et al., 2008). To block the kinase 
activity of EphBs over this long period of time, we treated cortical neuronal cultures with 
1μM 1-NA-PP1 from 10-21 DIV and exchanged media completely every three to four 
days. To image fine dendritic structures, we transfected neurons with GFP at 10 DIV and 
subsequently fixed and stained them with antibodies to GFP at 21 DIV to enhance the 
fluorescent signal. To assess spine density, we counted spines per unit dendritic length 
over multiple segments of dendrite totaling more than 50 μm. We found no significant 
change in the number of spines or their morphology in AS-EphB TKI or WT neurons 
after treatment with 1-NA-PP1 (Figure 4.3A, B). We conclude that EphB tyrosine kinase 
activity does not regulate dendritic spine development in dissociated cortical neurons.   102
 
Figure 4.3: EphB tyrosine kinase activity is not required for dendritic spine 
development in culture 
(A) Representative images of dendritic spines from cultured cortical neurons treated with 
vehicle or 1 μM 1-NA-PP1 from 10-21 DIV. Neurons were transfected at 10 DIV with 
GFP and stained against GFP after fixation to allow visualization of fine dendritic 
processes. 
(B) Quantification of spine density and spine length from (A). Data are mean ± SEM. N = 
25-33 neurons / condition. 
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The use of dissociated neurons has limitations, as these neurons are not able to 
form connections in a circuit as they would in vivo. In addition, dissociated cultures are a 
heterogeneous mix of several cell populations; therefore, changes in one subset of 
neurons may be masked by a surrounding class of neurons. To investigate the role of 
EphB tyrosine kinase signaling in a more physiological context, we studied spinogenesis 
in an intact circuit where the architecture of the hippocampus is preserved. We prepared 
organotypic slices of the hippocampus from postnatal day 6 or 7 (P6/7) WT or AS-EphB 
TKI pups. To visualize fine dendritic morphology, neurons were biolistically transfected 
using gold bullets containing a plasmid encoding GFP at 2 DIV. 
We incubated AS-EphB TKI or WT slices in vehicle or 1-NA-PP1 (250 nM-5 
μM) for 8 DIV during the peak of spinogenesis and measured spine density and length in 
both apical and basal dendrites from pyramidal neurons. Similar to results in dissociated 
cultures, we found no change in the density or length of spines in apical (Figure 4.4A, B) 
or basal (Figure 4.4C, D) dendrites. High doses of 1-NA-PP1 (5 uM) led to small, but 
statistically insignificant reductions in spine density for both AS-EphB TKI and WT 
neurons, suggesting a possible off-target effect at this dose (Figure 4.4B). There was also 
a small increase in length that was specific to AS-EphB TKI neurons, but this trend was 
not significant as assessed by two-way ANOVA (F(1,62)=1.35, p=0.25). Our data therefore 
support the conclusion that the tyrosine kinase activity of EphBs is not required for the 
development of dendritic spines in hippocampal slices.   104
 
Figure 4.4: EphB tyrosine kinase signaling is not required for dendritic spine 
development in hippocampal slices 
(A) Organotypic slices from P6/7 mouse pups were treated with vehicle or 1-NA-PP1 
(1uM) from 0-8DIV and biolistically transfected with GFP at 2-3 DIV. Representative 
images of apical spines. 
(B) Quantification of apical spine density and spine length. Data are mean ± SEM. N 
(neurons) = WT Vehicle (21), WT 250 nM 1-NA-PP1 (14), WT 1 μM 1-NA-PP1 (11), 
WT 5 μM 1-NA-PP1 (7), AS-EphB TKI Vehicle (30), AS-EphB TKI 250 nM 1-NA-PP1 
(18), AS-EphB TKI 1 μM 1-NA-PP1 (17), AS-EphB TKI 5 μM 1-NA-PP1 (10). 
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Figure 4.4 (continued) 
(C) Representative images of basal spines. 
(D) Quantification of basal spine density and spine length. 
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To compare our findings to acute loss-of function of EphB2 in the same context, 
we attempted RNAi knockdown of EphB2 using a vector (psuper) based strategy to 
express previously published shRNA hairpins (Kayser et al., 2006; Kayser et al., 2008). 
We selected a dose of EphB2 hairpin routinely used in our laboratory that did not affect 
the viability of cells. As a control, we used a scrambled hairpin previously generated in 
our lab that has no known targets. Cells were biolistically transfected with the control or 
EphB2 shRNA from 2-8 DIV. We found no difference in spine density or morphology 
between control and EphB2 hairpin-transfected cells, indicating that EphB2 alone is not 
required for spinogenesis in this context (Figure 4.5A, B). As an important caveat, we 
were not able to verify the level of EphB2 knockdown in the individual neurons that were 
analyzed, so it is possible that residual EphB2 was sufficient to drive spinogenesis. 
Knockdown of multiple EphBs is more challenging, and carries more risk of cell toxicity, 
but we are currently generating multiple hairpins that may be used to revisit this question.   107
 
Figure 4.5: Analysis of dendritic spines in EphB2 shRNA-transfected neurons 
(A) Organotypic slices from P6/7 mouse pups were transfected with control RNAi or 
EphB2 RNAi from 2-8DIV. Representative images of apical spines. 
(B) Quantification of apical spine density and spine length. Data are mean ± SEM. N = 
10-16 neurons / condition. 
(C) Representative images of basal spines. 
(D) Quantification of basal spine density and spine length.   108
 
4.3 Discussion 
We have demonstrated that in several developmental contexts EphB tyrosine 
kinase function is not required for synapse or spine formation. Blocking the kinase 
signaling of EphBs in both culture and slice had no effect on synapse number by 
immunocytochemistry or electrophysiology and no effect on spine number or 
morphology in culture or slice. 
Consistent with these results, we find very low or even absent levels of 
endogenous EphB phosphorylation in cultures under a number of conditions at multiple 
timepoints, as assessed through both western blot and immunocytochemistry. This is true 
even at times when EphBs (and ephrin-Bs) are highly expressed, indicating that the ratio 
of activated EphBs to total EphBs is incredibly low (Figure 1.2). While it is possible that 
EphB tyrosine kinase function is rarely activated (and if so, only for a short time), such as 
when a dendritic filopodium comes in contact with an axon, it is also possible that EphBs 
are not activated in these contexts and are signaling through kinase-independent 
mechanisms. 
Our data are consistent with a role for different aspects of EphB signaling, such as 
PDZ interactions, in mediating spine development. The clustering of PDZ-domain 
containing synaptic proteins or the recruitment of NMDA receptors via the EphB 
extracellular region may initiate or stabilize the formation of excitatory synapses during 
synaptogenesis (Dalva et al., 2000). 
Importantly, since our experiments studying synaptogenesis all yielded negative 
results, it is still possible that inhibition of EphB tyrosine kinase function would have   109
some effect in another experimental context where EphBs play a more active role. 
However, we have chosen timepoints and conditions that encompass the majority of 
spine formation and synapotogenesis and still see no effect of EphB tyrosine kinase 
inhibition. 
Another possibility is that most acute manipulations target individual cells and 
that our manipulations affect every cell. Thus, competition between cells for the relative 
amount of EphB might be more important than the absolute value of EphB activation. 
However, we find this unlikely given the strong phenotypes reported in EphB TKO mice 
where EphBs are absent from all cells, not just a subset (Henkemeyer et al., 2003). 
Alternatively, it remains possible that EphBs are not involved in synaptogenesis 
or spine formation directly. Ideally, an acute control to test EphB involvement at a certain 
timepoint would address this possibility. However, this goal is not trivial. Indeed, this 
challenge was the basis for our aim of designing AS-EphB TKI mice. Given the 
limitations of RNAi, especially for three separate targets, a loxP-based conditional 
knockin would be the best approach. The ephB1, ephB2, and ephB3 genes could be 
acutely deleted by CRE-mediated excision. CRE- transfected WT mice or mock-
transfected conditional mice would serve as excellent controls for toxicity effects. A 
number of molecules have been identified as mediators of synapse development, usually 
by RNAi, and our results may confirm that synaptogenesis and spine formation are 
particularly sensitive to these manipulations. The conditional knockout approach would 
overcome this hurdle and greatly clarify this question. 
Since EphB tyrosine kinase activity is not required for the development of 
excitatory synapses, it will be important to test whether the kinase activity of EphBs   110
functions instead in the plasticity of synapses, as multiple reports have identified a role 
for EphBs in long-term potentiation (LTP) in the hippocampus (Grunwald et al., 2001; 
Henderson et al., 2001). 
 
4.4 Materials and methods 
Electrophysiology: 
Whole-cell voltage clamp recordings were obtained using an Axopatch 200B 
amplifier at 25°C. During recordings, neurons were perfused with artificial cerebrospinal 
fluid containing 127 mM NaCl, 25 mM NaHCO3, 1.25 mM Na2HPO4, 2.5 mM KCl, 2 
mM CaCl2, 1 mM MgCl2, 25 mM D-glucose, and saturated with 95% O2, 5% CO2. 
Vehicle or 1-NA-PP1 treatment was begun at 3 DIV and continued throughout recordings. 
The internal solution for mEPSC analysis contained 120 mM cesium methane sulfonate, 
10 mM HEPES, 4 mM MgCl2, 4 mM Na2ATP, 0.4 mM Na2GTP, 10 mM sodium 
phosphocreatine and 1 mM EGTA. Osmolarity and pH were adjusted to 310 mOsm and 
7.3 with Millipore water and CsOH, respectively. 
mEPSCs were isolated by exposing neurons to 0.5 μM tetrodotoxin, 50 μM 
picrotoxin, and 10 μM cyclothiazide (all from Tocris Bioscience). Cells were allowed a 5 
minute equilibration period before recordings began. Cells with series resistance larger 
than 25 MΩ during the recordings were discarded. Data were analyzed in IgorPro 
(Wavemetrics) using custom-written macros. For each trace, the event threshold was set 
at 1.5 times the root-mean-square current. Currents were counted as events if they 
crossed the event threshold, had a rapid rise time (1.5 pA/ms) and had an exponential 
decay (τ<50 ms for mEPSC).   111
  As a control for inhibition of EphBs, concurrent plates of neurons were treated 
with inhibitor and at the time of recording were stimulated with ephrin-B1 for 30 minutes. 
Neurons were lysed in 1x SDS-sample buffer, run on western blot and probed with rabbit 
anti-phospho-Eph and mouse anti-β-actin (Abcam). 
 
Synaptic puncta colocalization assay 
Hippocampal neurons were cultured as described in Chapter 2. Neurons were 
transfected with GFP at 10 DIV using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol. Neurons were fixed in 4% PFA / 2% sucrose in PBS and stained 
with mouse anti-PSD-95 (Pierce) and rabbit anti-synapsin (Millipore) in 0.1% gelatin, 
0.3% Triton-X 100, 0.01% sodium azide in PBS. Images were obtained on a Zeiss Pascal 
confocal microscope, using a 63x objective with sequential acquisition settings at 1024 x 
1024 pixel resolution. 5 stacks of 0.5μm thickness were acquired for each neuron. 
Synapse density was calculated using custom-written MATLAB software. Unbiased 
image thresholds for synaptic marker channels were set at the mean pixel intensity plus 
two standard deviations for each channel. Thresholded images were segmented and 
objects of less than 4 pixels were removed. Synapses were defined as areas of triple 
overlap between the GFP, pre-synaptic channel (synapsin), and post-synaptic channel 
(PSD-95) greater than 3 pixels, and synapse density was determined by dividing the 
number of synapses by the area of the thresholded GFP dendrites. 
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Organotypic slices 
Hippocampal organotypic slices were prepared in ice cold dissection media (1 
mM CaCl2, 5 mM MgCl2, 10mM D-glucose, 4 mM KCl, 26 mM NaHCO3, 218 mM 
sucrose, 1.3 mM sodium phosphate, and 30 mM HEPES, pH 7.4). Brains were isolated 
from P6/7 pups, and hippocampi were excised and chopped into 400 µm sections. Slices 
were cultured on Millicell cell culture inserts (Millipore) in media containing 20% horse 
serum, 1 mM L-glutamine, 0.0012% ascorbic acid, 1 µg/mL insulin, 1 mM CaCl2, 2 mM 
MgCl2, 2.3 mg/mL glucose, 0.44 mg/mL NaHCO3, 7.16 mg/mL HEPES in MEM. 
 
Analysis of dendritic spines 
For dissociated neuron experiments, cortical neurons were cultured as described 
in Chapter 2 and grown on a monolayer of astrocytes on glass coverslips. Neurons were 
treated with vehicle or PP1 derivatives at 10 DIV and media was changed entirely every 
3-4 days (using neuronally preconditioned media). Neurons were transfected with GFP at 
10 DIV using Lipofectamine 2000 and fixed with 4%PFA/2%sucrose in PBS at 21 DIV. 
Coverslips were stained for GFP and mounted on slides using Fluoromount-G. 
Neurons were imaged on a Zeiss Pascal confocal microscope, using a 63x 
objective, and maximal z-projections were analyzed using Metamorph software. Multiple 
sections of dendrite totaling > 50 µM were counted for each neuron. 
For experiments in slice, hippocampal slices were treated with vehicle or PP1 
derivatives at 2 DIV and media/drug were fully replaced every 2-3 days. At 2-3 DIV, 
GFP (or GFP + hairpins) was biolistically transfected using a Helios gene gun. DNA 
bullets were prepared from 1.6 µm gold microcarrier particles (Biorad). After 8 DIV,   113
slices were fixed in 2.5% PFA / 4% sucrose in PBS for 1 hour and stained with chicken 
anti-GFP (Aves Labs) and rabbit anti-NeuN (Millipore) antibodies to visualize the 
structure of hippocampal fields. Basal and apical dendrites were analyzed separately and 
sections of dendrite totaling > 50 µM were counted for each neuron. 
 
shRNA constructs 
Published shRNA constructs were obtained from the laboratory of Matthew Dalva 
(Kayser et al., 2006; Kayser et al., 2008). The EphB2 hairpin sequence was: 
AGCCGGCGCCATCTATGTC. As a control, we used a hairpin that originally targeted 
Mef2 but contained two mutations: GTATCTCTCTGGTCGCTCC (Flavell et al., 2006). 
DNA bullets consisted of 10 µg shRNA + 25 µg GFP + 15 µg pcs2+ empty vector per 
12.5 mg gold particles.   114
Chapter 5 
Conclusion   115
EphBs play a vital role in the development of the nervous system. In an attempt to 
understand their function, numerous studies have catalogued the deficits observed when 
EphBs are perturbed. However, these experiments have suffered from severe constraints: 
they cannot isolate the specific signaling modalities of EphBs at precise stages of 
development. As a result, the EphB field has produced an abundance of data and a dearth 
of firm conclusions. 
At the initiation of our project, we identified four major hurdles to studying 
EphBs. First, since EphBs are involved at almost every stage of development, only acute 
manipulations can identify specific phenomena as primarily controlled by EphBs. Second, 
the multiple domains of EphBs make it difficult to isolate functions of specific signaling 
modalities. Third, the presence of three partially redundant EphB receptors in the brain 
makes loss-of-function experiments challenging. Finally, most perturbations of EphB 
signaling do not contain suitable controls to ensure that the observed phenomena are a 
result of EphB manipulation. 
We set out to overcome these hurdles and devise a novel approach that would 
facilitate well-controlled and temporally precise experiments. We have developed a 
chemical-genetic strategy to acutely inhibit the kinase signaling of EphB receptors in 
vitro and in vivo. We have demonstrated the specificity and effectiveness of inhibition in 
our analog-sensitive EphB triple knockin mice and studied these mutant kinases in the 
context of axon guidance and synaptogenesis. 
Using the AS-EphB TKI mice, we have definitively shown a requirement for 
EphB tyrosine kinase activity in the guidance of ventrotemporal retinal ganglion cell 
axons at the optic chiasm. Furthermore, we have resolved a major controversy in the field   116
of Eph research by identifying EphB tyrosine kinase signaling as vital for the formation 
of the corpus callosum, the anterior commissure, and corticofugal tracts. Our experiments 
provide clear mechanistic data about the nature of EphB signaling in a field replete with 
confusing studies. Indeed, our results call into question previous experiments that have 
relied on overexpression paradigms and mutant mice. 
While we have focused on axon guidance and synaptogenesis, the experiments 
detailed in this thesis demonstrate the utility of the chemical-genetic approach for 
studying EphB signaling in general. The AS-EphB TKI mice should lay the groundwork 
for further studies of EphBs that will greatly clarify their signaling and may identify new 
functions in the developing and mature organism. Additionally, the acute and reversible 
nature of our system make it ideal to study dynamic cell biological processes involving 
EphBs, such as receptor trafficking, internalization, and movements along the membrane. 
The determination that kinase activity is required for axon guidance still leaves a 
major question: does the relevant signaling pathway stem from autophosphorylation and 
recruitment of docking proteins or from the phosphorylation of protein substrates. AS 
kinases accept orthologous ATP analogs that can directly label the targets of the kinase. 
We should also be able to use the AS-EphB TKI mice to identify direct targets for the 
first time (Banko et al., 2011). The disadvantage of this technique is that the current 
labeling ATP orthologues require permeabilizing conditions to enter the cell. 
Nevertheless, given the scarcity of known axon guidance pathways, determination of 
EphB substrates in the relevant neurons could be a powerful approach. 
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Model for EphB receptor tyrosine kinase signaling in nervous system development 
Considering the data available before our studies, a reasonable model in the 
context of axon guidance would be as follows: when EphBs are present in the growth 
cone, the kinase activity is essential, but when ephrins are acting at the growth cone, 
EphB tyrosine kinase activity is not required for guidance. This hypothesis could be 
falsified by finding axon guidance decisions that are EphB-dependent, where ephrin-Bs 
are predominantly expressed on the growth cone. 
Surprisingly, based on current expression data, anterior commissure and corpus 
callossum fibers appear to be such an example where EphBs are not highly expressed on 
the axons (Michael Robichaux and Chris Cowan, unpublished). How would the kinase 
activity of EphBs mediate repulsion of an ephrin-B-expressing growth cone? As Bush et 
al. have demonstrated, the extracellular domain of Ephs can cause this collapse (Bush and 
Soriano, 2009). It is possible that the adhesive nature of the ephrin/Eph interaction 
dominates in vivo unless the EphB-expressing cell can disrupt this interaction (through a 
kinase-dependent process). Our studies provide some evidence that this is unlikely to be 
mediated by surface expression, but further study is warranted. Alternatively, EphBs 
could lead to morphological changes in the guidepost cell that cause it to retract from the 
growth cone, thus freeing the axon from the adhesive interaction. Live-imaging of these 
two interacting cell types could begin to test this hypothesis. 
Based on our data, we propose a model in which the tyrosine kinase activity of 
EphBs is required for repulsive interactions such as axon guidance, but is not required for 
adhesive interactions such as synapse formation. This hypothesis is consistent with a 
theory proposed by Holmberg et al. in which the amount of kinase activation predicts the   118
strength of repulsion (Holmberg and Frisen, 2002). Furthermore, inhibiting kinase-
activity in a normally repulsive context (such as axon guidance) may lead to unnatural 
adhesion. Thus, it will be interesting to study the misprojected axons we observed in the 
optic tract, corpus callosum, anterior commissure, and corticofugal tracts. It will also be 
important to search for any counterexamples to our model, such as an adhesive 
interaction that is kinase-dependent. 
Missing from our study is a clear EphB loss-of-function phenotype in the context 
of our AS-EphB TKI experiments. Thus, it is still formally possible that all EphB 
signaling, at least all forward signaling, is kinase dependent. An appropriate solution to 
this deficiency is to generate specific hairpins to all three neuronal EphBs, an approach 
our lab is currently taking. 
 
Outstanding questions 
Based on our findings, it is likely that the use of lacZ mutants and dominant 
negatives can lead to unreliable results. Therefore, it will be worthwhile to revisit a 
number of other developmental processes that rely on EphBs and determine whether they 
are kinase-dependent. Using the reversibility of the inhibitors will also allow the ability to 
pinpoint a specific temporal window when these events are occurring. Notably, all of our 
experiments have been conducted with triple knockin mice. In the future, it may be worth 
separating AS-EphB1, AS-EphB2, and AS-EphB3 in order to investigate whether their 
kinase functions play differing roles in development. 
In our in vivo experiments, we generally saw partial reductions in axon tracts, 
suggesting the possibility that EphB tyrosine kinase activity was not fully inhibited. To   119
this point, we have used subcutaneous injections of 1-NA-PP1, but developing an oral 
delivery method or a releasable capsule could improve future experiments. In addition, 
new PP1 derivatives are being developed, and testing their potency on our AS mutants 
could yield more suitable inhibitors. 
Isolation of EphB signaling in the adult has proven extremely challenging. With 
our chemical-genetic approach, previously inaccessible questions now become tractable. 
This exploration of how EphBs might mediate the maintenance, plasticity, and 
regeneration of the adult nervous system beckons as the next frontier in the field of Eph 
biology.   120
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